Other diseases of intestine

K11_OTHINT

intestinal disease: A non-neoplastic or neoplastic disorder that affects the small or large intestine.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K63 Hospital discharge: ICD-9 — 569[5-9] Hospital discharge: ICD-8 — 569 Hospital discharge: excluded ICD-8 — 5690[6-7] Cause of death: ICD-10 — K63 Cause of death: ICD-9 — 569[5-9] Cause of death: ICD-8 — 569 Cause of death: excluded ICD-8 — 5690[6-7] 2 out of 7 registries used, show all original rules.	8126
4. Check minimum number of events None	8126
5. Include endpoints None	8126
6. Filter based on genotype QC (FinnGen only)	7301

Control definitions (FinnGen only)

Control exclude: K11_INTESTOTH

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: K55-K63
Name in latin: Alii morbi intestini

NAME	K11_OTHINT
CONTROL_EXCLUDE	K11_INTESTOTH
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K63
HD_ICD_9	569[5-9]
HD_ICD_8	569
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL	5690[6-7]
COD_MAINONLY
COD_ICD_10	K63
COD_ICD_9	569[5-9]
COD_ICD_8	569
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL	5690[6-7]
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other diseases of intestine based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	35557	18270	16907
Only index persons	28068	14716	13352
Unadjusted period prevalence (%)
Whole population	0.50	0.52	0.47
Only index persons	0.53	0.54	0.51
Median age at first event (years)
Whole population	64.22	65.59	62.79
Only index persons	63.47	64.36	62.49

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7301	3579	3722
Unadjusted period prevalence (%)	1.49	1.27	1.71
Median age at first event (years)	66.75	65.33	68.11

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7573: Matched controls
75726

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

WX408

NOMESCO Finland

General anesthesy, balanced

2.6

312.0

2501

11942

P01AB01

ATC

metronidazole; oral, rectal

2.5

309.5

3251

17613

K56.7

ICD-10 Finland

Ileus, unspecified

201.1

307.7

215

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

68.5

307.7

226

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

318.9

307.7

506

K57.2

ICD-10 Finland

Diverticular disease of large intestine with perforation and abscess

111.8

307.7

362

JN3AD

NOMESCO Finland

Abdominal CT examination

5.1

307.7

1772

4312

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

6.7

307.7

1110

1880

JFB00

NOMESCO Finland

Partial resection of small intestine

27.7

307.7

467

179

JN3BD

NOMESCO Finland

Extensive abdominal CT

5.2

307.7

1232

2726

WX302

NOMESCO Finland

Thoracal epidural anesthesy

5.2

307.7

785

1640

UJF30

NOMESCO Finland

Ileoscopy through colon

11.8

307.7

1973

2203

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

13.1

307.7

370

296

K65.0

ICD-10 Finland

Acute peritonitis

17.7

307.7

319

188

K59.09

ICD-10 Finland

Constipation, unspecified

6.5

307.7

578

953

UJF32

NOMESCO Finland

Coloscopy

8.2

307.7

3574

7404

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

24.0

307.7

271

117

K62.1

ICD-10 Finland

Rectal polyp

72.9

307.7

192

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

3.2

307.7

3289

14639

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

13.8

307.7

1529

1367

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

6276.4

307.7

1546

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

4.2

307.7

981

2599

K63.5

ICD-10 Finland

Polyp of colon

627.3

307.7

3930

130

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

1097.8

307.7

316

K63.9

ICD-10 Finland

Disease of intestine, unspecified

139.2

307.7

507

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.7

307.7

3179

12370

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

9.2

307.7

602

702

A06AC01

ATC

ispaghula (psylla seeds); oral

3.0

307.7

2289

9642

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

6.2

307.7

730

1276

JAH00

NOMESCO Finland

Laparotomy

15.1

307.7

640

460

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

27.0

307.7

2507

1363

WX402

NOMESCO Finland

General anaesthesia

2.7

303.9

2275

10481

K60.3

ICD-10 Finland

Anal fistula

152.0

299.1

149

K63.8

ICD-10 Finland

Other specified diseases of intestine

437.4

297.2

296

56909

ICD-8 Finland

Other diseases of intestines and peritoneum, Unspecified

+∞

276.8

264

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

20.3

275.1

211

107

TPH07

NOMESCO Finland

Cathetrisation of artery

3.1

267.0

1339

4953

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.0

262.5

810

2195

K63.2

ICD-10 Finland

Fistula of intestine

+∞

262.0

250

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

5.6

259.8

519

989

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

245.6

2119

10291

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

4.9

239.9

558

1213

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

5.4

239.8

493

963

UJF92

NOMESCO Finland

Capsular endoscopy

9.3

234.6

286

318

K63.0

ICD-10 Finland

Abscess of intestine

+∞

232.5

222

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.2

225.0

4166

27446

D64.9

ICD-10 Finland

Anaemia, unspecified

3.0

224.2

1162

4350

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

22.8

223.7

163

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

20.6

222.1

169

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.5

221.6

1670

7570

K63.3

ICD-10 Finland

Ulcer of intestine

1084.0

216.6

211

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

5.1

216.1

474

979

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.8

213.0

1303

5320

JFF10

NOMESCO Finland

Loop enterostomy

25.3

212.9

149

JFA70

NOMESCO Finland

Suture of small intestine

38.1

212.8

131

ZXD05

NOMESCO Finland

Urgent procedure

2.2

210.4

2507

13827

6453

FHL

Radical surgery of hemorrhoids

99.6

208.3

108

ZXE00

NOMESCO Finland

One hour or less

2.1

207.8

3192

19407

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

4.9

207.8

473

1008

A07EC02

ATC

mesalazine; oral, rectal

4.5

207.3

528

1233

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

5.6

205.7

403

752

A02BC02

ATC

pantoprazole; systemic

2.2

205.4

5535

41477

K50.0

ICD-10 Finland

Crohn disease of small intestine

11.8

203.5

209

182

K92.1

ICD-10 Finland

Melaena

4.2

201.1

569

1440

R4110

NOMESCO Finland

Physiotherapy

2.2

200.2

2523

14173

56908

ICD-8 Finland

Other diseases of intestines and peritoneum, Alii definiti

+∞

198.8

190

K50.8

ICD-10 Finland

Other Crohn disease

11.8

195.7

201

175

Z93.3

ICD-10 Finland

Colostomy status

14.2

195.5

179

129

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

6.0

195.2

352

607

JHA00

NOMESCO Finland

Anal or perianal incision

28.3

194.9

131

K61.0

ICD-10 Finland

Anal abscess

36.1

193.9

121

ZXE10

NOMESCO Finland

More than one and less than three hours

2.1

193.4

3034

18463

D01

ICPC

Abdominal pain/cramps general

3.0

191.9

967

3547

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

3.3

188.0

763

2464

K50.9

ICD-10 Finland

Crohn disease, unspecified

11.8

186.2

191

166

JFB46

NOMESCO Finland

Resection of sigmoid colon

14.0

183.5

169

123

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

6.2

182.8

321

539

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.8

180.3

1056

4192

A07EA06

ATC

budesonide; oral, local oral

5.3

179.5

375

741

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

6.2

178.0

312

523

JFB30

NOMESCO Finland

Right hemicolectomy

8.8

177.3

225

263

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.3

175.5

1662

8250

K59.1

ICD-10 Finland

Functional diarrhoea

4.6

175.4

438

1005

ZXD10

NOMESCO Finland

Scheduled procedure

2.0

175.1

3099

19510

N02AX02

ATC

tramadol; systemic, rectal

2.0

174.9

3525

23206

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

12.8

174.5

170

136

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

5.7

169.8

326

596

JFF13

NOMESCO Finland

Terminal enterostomy

40.1

169.6

103

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

5.6

168.8

327

603

Z2221

NOMESCO Finland

Medical doctor

2.1

166.0

2207

12490

R10.0

ICD-10 Finland

Acute abdomen

5.3

162.8

340

671

TJF80

NOMESCO Finland

Ostomy education

9.2

162.2

198

220

UJG02

NOMESCO Finland

Proctoscopy

7.2

161.5

244

350

JAH01

NOMESCO Finland

Laparoscopy

4.2

160.8

452

1135

B01AB05

ATC

enoxaparin; parenteral

2.0

160.6

2690

16492

45599

ICD-8 Finland

Haemorrhoids

+∞

157.8

151

Z12.1

ICD-10 Finland

Special screening examination for neoplasm of intestinal tract

7.5

154.8

225

309

K59.0

ICD-10 Finland

Constipation

4.3

152.2

404

971

WX002

NOMESCO Finland

Sedation and analgesia

2.2

151.7

1655

8643

J01MA02

ATC

ciprofloxacin; systemic

1.9

150.6

3118

20409

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.3

149.8

1397

6843

K60.1

ICD-10 Finland

Chronic anal fissure

19.8

148.9

115

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

6.6

146.4

238

369

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

144.4

1328

6459

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

4.5

140.0

356

827

D06

ICPC

Abdominal pain localized other

2.9

139.9

707

2579

JFF23

NOMESCO Finland

Transversostomy

8.5

139.1

181

218

JN4AD

NOMESCO Finland

Body CT examination

2.3

137.5

1151

5369

56902

ICD-8 Finland

Other diseases of intestines and peritoneum, Proctitis haemorrhagica (ulcerosa)

+∞

136.9

131

ZXE20

NOMESCO Finland

More than three and less than five hours

2.3

134.1

1190

5687

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.8

133.0

428

1182

L04AX01

ATC

azathioprine; systemic

3.9

130.1

404

1088

JFB20

NOMESCO Finland

Ileocaecal resection

18.8

129.1

102

K57

ICD-10 Finland

Diverticular disease of intestine

8.7

127.7

162

189

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.5

127.2

322

745

K57.1

ICD-10 Finland

Diverticular disease of small intestine without perforation or abscess

17.7

126.7

103

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

4.8

125.5

290

623

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.0

125.0

1582

8665

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.4

124.5

988

4489

K50.1

ICD-10 Finland

Crohn disease of large intestine

9.9

124.1

143

147

Z3226

NOMESCO Finland

Physiotherapist

2.1

122.0

1484

8003

J01DB01

ATC

cefalexin; oral

2.0

121.7

6169

51803

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

19.6

120.0

H02AB06

ATC

prednisolone; systemic

1.7

119.0

3672

26506

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

14.8

117.7

105

J01MA12

ATC

levofloxacin; systemic

2.0

115.9

1528

8465

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.5

115.9

825

3564

C10AC01

ATC

colestyramine; oral

4.8

115.5

263

558

UJH02

NOMESCO Finland

Anoscopy

4.7

115.2

271

591

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

8.1

114.9

155

195

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

3.6

114.3

386

1100

D16

ICPC

Rectal bleeding

5.0

114.3

249

509

C03CA01

ATC

furosemide; systemic

1.8

113.7

2497

16291

N02BE01

ATC

paracetamol; systemic, rectal

2.4

113.7

6785

59472

A02BC05

ATC

esomeprazole; systemic

1.7

113.2

3002

20673

A06AD11

ATC

lactulose; oral

2.2

113.0

1124

5600

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

112.5

1300

6858

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

5.9

112.4

204

353

N03AX16

ATC

[U] pregabalin

1.9

112.3

1765

10370

K56.0

ICD-10 Finland

Paralytic ileus

561.3

112.2

111

K62.3

ICD-10 Finland

Rectal prolapse

29.9

112.0

WX892

NOMESCO Finland

Monitored bed care

2.6

110.9

721

2982

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.9

110.7

333

876

Z93.2

ICD-10 Finland

Ileostomy status

19.3

110.2

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.7

110.2

646

2538

ZX120

NOMESCO Finland

Intravenous

2.4

110.1

816

3586

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

109.3

1577

8994

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

107.0

1007

4899

Z71.8

ICD-10 Finland

Other specified counselling

1.8

106.8

2516

16688

JF1AD

NOMESCO Finland

Small bowel CT

14.5

106.6

UJD02

NOMESCO Finland

Gastroscopy

3.3

105.4

427

1366

K64.0

ICD-10 Finland

First degree haemorrhoids

6.0

105.0

188

321

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.2

104.5

1003

4916

JN4BD

NOMESCO Finland

Extensive body CT

2.3

104.3

922

4370

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

7.4

104.0

152

210

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

3.7

103.9

348

986

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

5.0

103.8

228

469

K51.5

ICD-10 Finland

Left sided colitis

4.6

102.9

246

543

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

9.0

102.0

126

142

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

10.3

101.3

113

111

JDA60

NOMESCO Finland

Closure of perforated ulcer of stomach

19.2

99.7

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

5.9

99.7

180

310

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

6.8

99.0

156

234

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

98.0

5200

42469

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

25.4

97.4

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

51.3

97.2

S18

ICPC

Laceration/cut

1.7

96.8

3671

27451

UJF30, ,

SPAT

8.0

96.5

131

166

B82

ICPC

Anaemia other/unspecified

3.8

95.8

296

793

JAH33

NOMESCO Finland

Opening of laparostomy

35.6

95.6

B01AB10

ATC

tinzaparin; parenteral

2.1

95.3

964

4813

K55.0

ICD-10 Finland

Acute vascular disorders of intestine

473.7

94.5

D18

ICPC

Change in faeces/bowel movements

4.2

94.0

253

613

R4190

NOMESCO Finland

Nutritional therapy

3.3

93.6

370

1165

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.3

93.0

785

3640

JFH10

NOMESCO Finland

Total colectomy and ileostomy

24.3

91.5

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

4.6

91.5

220

488

R50.9

ICD-10 Finland

Fever, unspecified

2.0

90.9

1154

6258

JAK03

NOMESCO Finland

Laparotomy and peritoneal irrigation

31.3

90.5

R06.0

ICD-10 Finland

Dyspnoea

1.7

90.5

2041

13248

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

90.0

2595

17992

JF1BD

NOMESCO Finland

Very extensive small bowel CT

15.9

89.8

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.8

89.5

483

1814

JFB50

NOMESCO Finland

Other resection of colon

19.1

89.2

D11

ICPC

Diarrhoea

2.2

88.2

791

3758

Z3231

NOMESCO Finland

Registered nurse

1.7

88.2

2057

13460

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.5

87.4

307

897

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

86.9

1062

5675

A02BC01

ATC

omeprazole; systemic

1.7

85.5

1947

12639

R02

ICPC

Shortness of breath/dyspnoea

2.0

85.0

1076

5820

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

84.3

1286

7403

JFB43

NOMESCO Finland

Left hemicolectomy

12.3

83.8

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

6.3

83.6

141

227

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

83.0

1512

9192

JFB33

NOMESCO Finland

Other resection comprising small intestine and colon

33.3

82.8

K64.1

ICD-10 Finland

Second degree haemorrhoids

5.5

82.7

162

301

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

82.0

1408

8404

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

22.4

81.8

WX882

NOMESCO Finland

High dependency care

3.6

80.8

273

777

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

3.9

80.3

243

641

XF600

NOMESCO Finland

Bloodpressure measurement

2.5

80.2

542

2273

K25.1

ICD-10 Finland

Gastric ulcer, Acute with perforation

13.2

80.1

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

17.1

79.8

H02AB07

ATC

prednisone; oral

2.0

79.8

1028

5586

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

18.7

79.5

M54.5

ICD-10 Finland

Low back pain

1.6

79.4

2506

17643

K62.2

ICD-10 Finland

Anal prolapse

30.8

79.3

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

79.3

2079

13967

K64.2

ICD-10 Finland

Third degree haemorrhoids

7.8

78.9

109

141

A29

ICPC

General symptom/complaint other

1.9

78.3

1100

6151

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

78.2

1629

10277

C187, 8148, 2

ICD-O-3

29.1

77.9

WVA20

NOMESCO Finland

Medicine administration

3.4

77.8

282

840

K62.0

ICD-10 Finland

Anal polyp

30.2

77.3

R53

ICD-10 Finland

Malaise and fatigue

1.7

76.5

1714

11023

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

76.4

3087

22994

A04

ICPC

Weakness/tiredness general

1.9

76.1

1116

6324

D12

ICPC

Constipation

3.4

76.0

286

873

A06AC51

ATC

ispaghula, combinations; oral

3.1

74.5

329

1105

A07EA02

ATC

hydrocortisone; rectal

4.7

74.5

175

381

A28

ICPC

Limited function/disability NOS

1.8

74.4

1428

8785

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.1

74.1

730

3590

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

9.9

73.9

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.8

73.7

393

1465

C07AB07

ATC

bisoprolol; oral

1.5

73.3

3746

29323

R11

ICD-10 Finland

Nausea and vomiting

2.3

73.0

608

2794

JFA80

NOMESCO Finland

Suture of colon

23.8

72.6

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

72.4

2670

19405

TKC20

NOMESCO Finland

Catheterisation of bladder

2.3

72.4

581

2628

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

72.1

3609

28084

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.3

71.6

280

875

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

3.8

71.5

226

615

K57.0

ICD-10 Finland

Diverticular disease of small intestine with perforation and abscess

705.0

71.2

A01

ICPC

Pain general/multiple sites

2.1

70.8

765

3893

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

70.7

3127

23647

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

6.1

69.4

120

198

M79.6

ICD-10 Finland

Pain in limb

1.5

69.4

3065

23140

N06AX21

ATC

duloxetine; oral

2.0

69.2

809

4236

K56.2

ICD-10 Finland

Volvulus

684.6

69.1

WW500

NOMESCO Finland

Blood transfusion

2.8

68.8

361

1334

B80

ICPC

Iron deficiency anaemia

3.7

68.2

217

593

K91.2

ICD-10 Finland

Postsurgical malabsorption, not elsewhere classified

30.2

68.1

R03AC02

ATC

salbutamol; inhalant

1.5

67.6

3750

29676

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.6

67.5

412

1643

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

14.3

67.2

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

20.5

67.1

JHD20

NOMESCO Finland

Incision of fistula-in-ano

664.2

67.1

N06AX11

ATC

mirtazapine; oral

1.6

66.8

2327

16620

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

4.4

66.7

171

399

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

66.2

540

2456

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.1

65.8

280

920

A41.9

ICD-10 Finland

Sepsis, unspecified

2.9

65.7

321

1141

K60.2

ICD-10 Finland

Anal fissure, unspecified

7.7

65.7

121

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

3.4

65.6

236

700

AA1AD

NOMESCO Finland

CT of head and brain

1.6

65.4

2184

15431

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

23.6

65.4

SPAT1125

SPAT

Stoma care and guidance

4.3

65.3

168

393

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.8

65.2

149

317

R03BB04

ATC

tiotropium bromide; inhalant

2.0

65.2

800

4257

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

65.2

747

3880

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.7

65.0

209

575

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

64.7

990

5667

Z2446

NOMESCO Finland

Social worker

2.4

64.4

456

1949

D92

ICPC

Diverticular disease

11.9

64.3

A02BC03

ATC

lansoprazole; oral

1.6

64.1

1965

13596

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

7.3

63.8

131

N05CF01

ATC

zopiclone; oral

1.6

63.7

2255

16128

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.4

63.5

446

1900

J02AC01

ATC

fluconazole; systemic

1.5

62.5

2431

17742

UJF02

NOMESCO Finland

Peroral enteroscopy

9.9

62.2

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

4.5

62.1

152

342

UKC02

NOMESCO Finland

Cystoscopy

1.8

62.1

1193

7303

56310

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Ulcerative colitis

10.7

61.8

K62.8

ICD-10 Finland

Other specified diseases of anus and rectum

12.0

61.7

A91

ICPC

Abnormal result investigation NOS

2.4

61.3

451

1961

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

61.2

1574

10414

N02AA05

ATC

oxycodone; systemic

1.7

61.2

1411

9077

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

60.3

2064

14614

L03

ICPC

Low back symptom/complaint

1.6

60.2

1950

13632

TK800

NOMESCO Finland

Hemodialysis

3.5

59.9

206

593

JFB40

NOMESCO Finland

Resection of transverse colon

18.9

59.6

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

59.5

1076

6467

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

5.5

59.4

114

208

L28

ICPC

Limited function/disability (L)

1.7

59.2

1421

9227

C08CA01

ATC

amlodipine; oral

1.5

58.9

3001

23110

D99

ICPC

Disease digestive system other

5.7

58.5

110

197

K55.2

ICD-10 Finland

Angiodysplasia of colon

201.6

58.1

JWW96

NOMESCO Finland

Other reoperation in gastroenterological surgery

19.7

58.1

JWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery

15.7

58.0

JHA20

NOMESCO Finland

Excision of lesion of anal canal or perianal tissue

9.5

57.7

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

4.7

57.5

134

290

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.4

57.3

402

1710

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

4.5

57.2

139

311

K51.8

ICD-10 Finland

Other ulcerative colitis

5.0

57.1

123

249

K59.9

ICD-10 Finland

Functional intestinal disorder, unspecified

5.9

56.7

102

175

K59.01

ICD-10 Finland

Constipation outlet obstruction type

71.5

56.1

C03DA01

ATC

spironolactone; oral

1.8

56.1

958

5654

JFG36

NOMESCO Finland

Closure of terminal colostomy with anastomosis to rectum

148.6

55.9

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.7

55.8

181

501

WX320

NOMESCO Finland

Spinalanesthesy

1.6

55.7

1806

12592

L17

ICPC

Foot/toe symptom/complaint

1.5

55.5

2162

15694

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

55.5

977

5817

5698C

ICD-9 Finland

Other disorders of intestine, Other specified disorders of intestine[PERFORATIO INTESTINALIS]

+∞

55.3

J01FF01

ATC

clindamycin; systemic

1.6

55.3

1870

13161

WZC30

NOMESCO Finland

Teaching

1.7

55.1

1266

8114

K50

ICD-10 Finland

Crohn disease [regional enteritis]

15.8

54.6

K55.8

ICD-10 Finland

Other vascular disorders of intestine

+∞

54.2

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

4.2

54.1

143

342

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

8.4

53.9

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

53.9

1903

13506

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

53.8

919

5421

B01AF02

ATC

apixaban; oral

1.7

53.7

1081

6681

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.2

53.6

494

2359

JAK00

NOMESCO Finland

Laparotomy and drainage of peritoneal cavity

21.2

53.2

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.1

53.2

522

2554

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

53.0

1051

6468

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.0

52.7

243

836

K30

ICD-10 Finland

Functional dyspepsia

1.9

52.7

727

4012

3AC01, ,

NOMESCO Finland

5.8

52.6

167

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

52.6

1313

8585

R15

ICD-10 Finland

Faecal incontinence

3.5

52.5

185

541

WX872

NOMESCO Finland

Intensive care

2.2

52.5

443

2040

K29.3

ICD-10 Finland

Chronic superficial gastritis

3.0

52.4

244

844

D75

ICPC

Malignant neoplasm colon/rectum

5.7

52.3

175

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

52.2

233

787

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

15.6

52.0

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

5.3

51.8

104

198

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.3

51.7

201

626

N05BA04

ATC

oxazepam; oral

1.6

51.6

1716

12000

K26.1

ICD-10 Finland

Duodenal ulcer, acute with perforation

17.6

51.5

L01BC06

ATC

capecitabine; oral

2.5

51.5

336

1382

C05AA08

ATC

fluocortolone; rectal, topical

1.8

51.5

852

4975

S97

ICPC

Chronic ulcer skin

2.1

51.5

523

2592

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

3.6

51.3

169

473

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

7.4

51.2

101

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

51.1

2235

16565

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

3.3

51.0

193

591

R51.80

ICD-10 Finland

Headache

1.8

50.7

919

5509

JAD10

NOMESCO Finland

Repair of incisional hernia

6.5

50.5

127

J01AA02

ATC

doxycycline; systemic

1.5

50.3

5548

48952

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

50.2

1831

13056

K65.9

ICD-10 Finland

Peritonitis, unspecified

11.4

50.0

U07

ICPC

Urine symptom/complaint other

2.0

49.9

616

3272

R19.4

ICD-10 Finland

Change in bowel habit

3.1

49.8

209

681

G47.3

ICD-10 Finland

Sleep apnoea

1.6

49.8

1658

11585

N06AX16

ATC

venlafaxine; oral

1.8

49.6

856

5058

K99

ICPC

Cardiovascular disease other

2.8

49.4

253

922

UJF34

NOMESCO Finland

Left colonoscopy

7.8

49.2

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

49.1

1317

8749

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

4.3

49.0

126

295

JFA15, ,

SPAT

4.9

48.8

107

220

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

48.8

2777

21621

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

48.6

566

2947

L29

ICPC

Musculoskeletal sympt/complt other

1.9

48.5

654

3578

ZXA05

NOMESCO Finland

Left side

1.5

48.3

1728

12256

56500

ICD-8 Finland

Anal fissure and fistula, Anal fissure

+∞

48.0

R03DC03

ATC

montelukast; oral

1.7

47.8

1046

6597

D94

ICPC

Chronic enteritis/ulcerative colitis

7.3

47.8

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.2

47.7

424

1994

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

47.6

1397

9473

ZXA00

NOMESCO Finland

Right side

1.5

47.6

1850

13347

S21

ICPC

Skin texture symptom/complaint

1.7

47.5

1113

7143

K29.7

ICD-10 Finland

Gastritis, unspecified

2.7

47.3

259

977

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

47.3

846

5046

M04AA01

ATC

allopurinol; systemic

1.7

47.2

1001

6260

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.1

47.1

198

646

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.3

47.1

353

1546

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

5.4

46.9

175

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

3.7

46.9

147

398

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

46.8

1178

7698

D50.8

ICD-10 Finland

Other iron deficiency anaemias

4.0

46.7

132

332

A02BA02

ATC

ranitidine; systemic

1.6

46.5

1266

8429

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

18.6

46.5

J01DA01

ATC

[U] cefalexin

1.4

46.5

4141

34830

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.5

46.2

300

1231

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

46.2

1283

8583

JKA20

NOMESCO Finland

Cholecystectomy

2.9

46.0

223

789

1470

FHL

Rectoscopy

13.0

46.0

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

45.9

717

4107

N03AX12

ATC

[U] gabapentin; oral

1.7

45.8

1047

6675

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

6.0

45.6

134

JGC01

NOMESCO Finland

Laparoscopic rectopexy

17.7

45.5

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.2

45.5

121

291

Z43.2

ICD-10 Finland

Attention to ileostomy

16.6

45.3

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.4

45.2

312

1317

R52.2

ICD-10 Finland

Other chronic pain

2.6

45.1

268

1054

R52.9

ICD-10 Finland

Pain, unspecified

1.8

44.9

688

3918

B03BA03

ATC

hydroxocobalamin; parenteral

2.1

44.8

423

2036

WX704

NOMESCO Finland

Intubation

1.9

44.4

603

3304

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

44.3

4690

40488

K61.1

ICD-10 Finland

Rectal abscess

440.3

44.3

K62.6

ICD-10 Finland

Ulcer of anus and rectum

7.9

44.2

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

44.2

642

3594

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

5.6

44.1

149

A97

ICPC

No disease

1.6

44.0

1372

9414

127

Kela drug reimbursment

Transplant complication

3.7

44.0

138

374

B81

ICPC

Anaemia vit B12/folate deficiency

2.4

43.7

304

1287

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

6.6

43.7

107

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

43.7

946

5941

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

43.3

1386

9562

WX290

NOMESCO Finland

Other blockage of nerve

1.4

43.2

2948

23562

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.8

43.2

743

4378

A11CC03

ATC

alfacalcidol; systemic

2.9

43.1

202

702

H02AB04

ATC

methylprednisolone; systemic

1.7

42.9

952

6015

E0000UV, ,

ATC

1.4

42.5

2728

21557

R31

ICD-10 Finland

Unspecified haematuria

1.8

42.4

751

4461

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.3

42.4

340

1532

WGA11

NOMESCO Finland

Planning of pain management

6.8

42.3

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

42.2

708

4139

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

8.0

42.1

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

4.3

42.0

109

257

J01FA06

ATC

roxithromycin; oral

1.4

41.8

2593

20352

Z43.3

ICD-10 Finland

Attention to colostomy

12.5

41.8

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

4.4

41.7

105

242

H02AB09

ATC

hydrocortisone; systemic

3.1

41.6

180

598

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.3

41.5

107

251

JF2AB

NOMESCO Finland

Colongraphy with X-ray

11.1

41.5

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

41.5

1689

12245

K64.3

ICD-10 Finland

Fourth degree haemorrhoids

9.5

41.5

SPAT1262

SPAT

Handing over of treatment supplies

1.6

41.3

1239

8414

J01MA14

ATC

moxifloxacin; systemic

1.8

41.2

629

3574

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

4.9

41.1

189

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

41.1

1574

11270

JF2BD

NOMESCO Finland

Extensive colon CT

7.4

41.1

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

41.0

1285

8811

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.8

41.0

125

332

207

Kela drug reimbursment

Chronic arrhythmias

1.6

41.0

1194

8054

R52.0

ICD-10 Finland

Acute pain

2.7

41.0

230

879

E87.6

ICD-10 Finland

Hypokalaemia

2.4

41.0

276

1152

R06AE07

ATC

cetirizine; oral

1.4

40.9

2761

21967

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

3.4

40.9

149

446

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

40.8

1823

13458

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.9

40.7

555

3042

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.9

40.7

193

675

4550A

ICD-9 Finland

Haemorrhoids, Internal haemorrhoids without mention of complication

+∞

40.7

J01CA04

ATC

amoxicillin; systemic

1.4

40.6

5599

50201

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.0

40.4

474

2470

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

9.6

40.3

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.0

40.3

442

2250

A99

ICPC

Disease/condition unspecnature/site

1.7

40.0

726

4339

R01AD09

ATC

mometasone; nasal

1.4

40.0

2813

22512

XF404

NOMESCO Finland

Ambulatory ECG

1.8

40.0

615

3502

256, ,

Kela drug reimbursment

15.3

39.9

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.9

39.9

182

N30.0

ICD-10 Finland

Acute cystitis

1.6

39.9

1052

6930

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

3.6

39.8

134

381

A11

ICPC

Chest pain NOS

1.8

39.7

597

3375

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.0

39.7

118

L01BB02

ATC

mercaptopurine; oral

5.1

39.7

164

G04CA02

ATC

tamsulosin; oral

1.5

39.6

1757

12937

WX610

NOMESCO Finland

Patient controlled analgesia

6.0

39.6

115

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

4.2

39.5

104

248

R42

ICD-10 Finland

Dizziness and giddiness

1.5

39.5

1552

11156

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.3

39.3

317

1432

N05BA01

ATC

diazepam; systemic, rectal

1.7

39.2

824

5125

JEA00

NOMESCO Finland

Appendectomy

2.1

39.0

381

1857

R74

ICPC

Upper respiratory infection acute

1.5

39.0

1816

13493

S29

ICPC

Skin symptom/complaint other

1.5

38.9

1394

9830

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.4

38.8

278

1193

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

38.8

1192

8129

K31.7

ICD-10 Finland

Polyp of stomach and duodenum

6.4

38.7

101

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.3

38.6

311

1404

N02BF02

ATC

pregabalin; oral

2.0

38.5

448

2328

L04AD02

ATC

tacrolimus; systemic

4.3

38.5

228

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

38.5

988

6463

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.2

38.1

315

1437

R35

ICD-10 Finland

Polyuria

1.9

38.1

487

2613

K59.8

ICD-10 Finland

Other specified functional intestinal disorders

10.1

38.0

D50

ICD-10 Finland

Iron deficiency anaemia

3.2

37.7

150

474

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

4.6

37.7

191

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

37.7

1148

7810

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

37.6

421

2157

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

37.6

467

2482

4556A

ICD-9 Finland

Haemorrhoids, Unspecified haemorrhoids without mention of complication

+∞

37.5

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

37.5

1307

9154

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

37.4

1686

12431

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

6.8

37.3

T90

ICPC

Diabetes non-insulin dependent

1.4

37.1

1828

13704

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

37.1

1787

13342

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

36.9

765

4737

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

36.9

340

1621

L01

ICPC

Neck symptom/complaint

1.6

36.8

990

6543

R96

ICPC

Asthma

1.7

36.8

674

4037

K56.1

ICD-10 Finland

Intussusception

+∞

36.5

B01AB04

ATC

dalteparin; parenteral

2.1

36.4

375

1865

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

3.5

36.1

122

348

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

36.1

821

5208

Z93

ICD-10 Finland

Artificial opening status

9.0

35.9

WW200

NOMESCO Finland

Immunization

2.6

35.9

207

802

JFA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in colon

9.6

35.9

QBA10

NOMESCO Finland

Incision of skin of trunk

4.2

35.8

228

A04AA01

ATC

ondansetron; systemic, rectal

1.8

35.8

578

3337

M25.5

ICD-10 Finland

Pain in joint

1.4

35.8

2068

15934

GD1AD

NOMESCO Finland

Thorax CT examination

1.9

35.4

480

2624

C209, 8148, 2

ICD-O-3

11.3

35.3

K96

ICPC

Haemorrhoids

2.8

35.2

181

662

R07.3

ICD-10 Finland

Other chest pain

1.7

35.1

656

3949

130

Kela drug reimbursment

Malignant tumour

1.7

35.0

688

4199

R63.4

ICD-10 Finland

Abnormal weight loss

2.3

35.0

278

1248

JHD33

NOMESCO Finland

Completing incision of fistula-in-ano

348.9

35.0

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

35.0

483

2657

K62.7

ICD-10 Finland

Radiation proctitis

43.2

34.9

L04AA06

ATC

mycophenolic acid; systemic

3.0

34.9

152

507

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

3.3

34.9

135

420

U02

ICPC

Urinary frequency/urgency

1.6

34.8

937

6188

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

6.7

34.8

JFA45

NOMESCO Finland

Endoscopic contact coagulation in colon

8.4

34.7

N05AH04

ATC

quetiapine; oral

1.6

34.6

1016

6846

B03XA02

ATC

darbepoetin alfa; parenteral

2.9

34.5

167

591

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.1

34.5

323

1549

D02

ICPC

Abdominal pain epigastric

2.0

34.1

380

1945

I50.0

ICD-10 Finland

Congestive heart failure

1.8

34.0

529

3020

U71

ICPC

Cystitis/urinary infection other

1.9

33.9

423

2250

K60.0

ICD-10 Finland

Acute anal fissure

6.9

33.9

Y83.2

ICD-10 Finland

Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

8.1

33.7

A27

ICPC

Fear of other disease NOS

2.0

33.7

365

1849

A07EC01

ATC

sulfasalazine; oral, rectal

1.8

33.6

516

2932

SPAT1255

SPAT

Intravenous administration of medicine

1.9

33.5

464

2554

D64.8

ICD-10 Finland

Other specified anaemias

3.1

33.5

143

472

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.3

33.4

255

1125

ZXD20

NOMESCO Finland

Day surgery

1.6

33.4

816

5264

5698X

ICD-9 Finland

Other disorders of intestine, Other specified disorders of intestine[MORBUS INTESTINI ALIA DEFINITA]

+∞

33.3

G44.2

ICD-10 Finland

Tension-type headache

1.6

33.3

753

4764

K07

ICPC

Swollen ankles/oedema

2.0

33.3

359

1815

A08

ICPC

Swelling

1.9

33.2

403

2123

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

33.1

1678

12606

Z94.0

ICD-10 Finland

Kidney transplant status

4.0

33.0

234

R03BA05

ATC

fluticasone; inhalant

1.5

32.9

1095

7574

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.8

32.8

540

3134

N06AB04

ATC

citalopram; systemic

1.5

32.8

1266

9031

M48.0

ICD-10 Finland

Spinal stenosis

1.6

32.7

846

5529

JFF30

NOMESCO Finland

Other colostomy

35.2

32.7

K02.1

ICD-10 Finland

Caries of dentine

1.3

32.7

3775

32295

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.7

32.6

180

683

L04AC05

ATC

ustekinumab; parenteral

7.0

32.6

M03BX02

ATC

tizanidine; oral

1.3

32.5

4053

35056

A07DA03

ATC

loperamide; oral

2.4

32.4

233

1002

J01FA10

ATC

azithromycin; systemic

1.3

32.4

3566

30282

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.9

32.3

436

2379

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

32.3

1728

13093

5608A

ICD-9 Finland

Intestinal obstruction without mention of hernia, Other specified intestinal obstruction[OBSTRUCTIO INTESTINALIS ,ADHESIONES INTRAABDOMINALE]

+∞

32.3

J45.1

ICD-10 Finland

Nonallergic asthma

1.8

32.3

466

2598

A06AX04

ATC

linaclotide; oral

13.0

32.3

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

32.2

1773

13500

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.7

32.2

681

4234

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

6.1

32.2

R03BA02

ATC

budesonide; inhalant

1.5

32.1

1092

7588

A03FA02

ATC

cisapride; oral, rectal

1.9

32.0

444

2444

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

31.9

2866

23596

Z01.7

ICD-10 Finland

Laboratory examination

1.5

31.9

1072

7427

JHD30

NOMESCO Finland

Incomplete incision of fistula-in-ano

318.4

31.9

R4120

NOMESCO Finland

Occupational therapy

1.9

31.8

446

2463

WX199

NOMESCO Finland

Other local analgesia

2.2

31.8

270

1245

Z01.2

ICD-10 Finland

Dental examination

1.3

31.8

2924

24156

B01AA03

ATC

warfarin; systemic

1.5

31.8

1304

9407

1370

FHL

Colonoscopy, whole colon

7.0

31.7

6451

FHL

Dilatation

88.0

31.7

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

31.7

873

5790

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.7

31.6

594

3578

N18.8

ICD-10 Finland

Other chronic renal failure

2.6

31.6

187

735

K25.5

ICD-10 Finland

Gastric ulcer, Chronic or unspecified with perforation

10.3

31.5

N99.4

ICD-10 Finland

Postprocedural pelvic peritoneal adhesions

5.2

31.5

127

C01DA14

ATC

isosorbide mononitrate; oral

1.5

31.5

1048

7245

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.5

31.4

194

778

WX730

NOMESCO Finland

Conventional respirator

3.1

31.3

131

427

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

31.3

592

3572

H05BX01

ATC

cinacalcet; oral

5.2

31.2

121

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.5

31.1

206

853

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.9

31.1

422

2307

N01

ICPC

Headache

1.7

31.1

552

3273

N05CF02

ATC

zolpidem; oral

1.5

31.0

1055

7327

X58

ICD-10 Finland

Exposure to other specified factors

1.6

30.8

914

6160

L02

ICPC

Back symptom/complaint

1.7

30.8

597

3625

K64.8

ICD-10 Finland

Other specified haemorrhoids

5.5

30.7

108

J01EA01

ATC

trimethoprim; systemic

1.4

30.7

1521

11355

A03CA02

ATC

clidinium and psycholeptics; oral

2.0

30.7

333

1687

JF2AD

NOMESCO Finland

Colon CT

8.1

30.7

M01AB05

ATC

diclofenac; systemic, rectal

1.3

30.7

4486

39540

JFK00

NOMESCO Finland

Division of adhesive band in intestinal obstruction

160.7

30.7

M01AH01

ATC

celecoxib; oral

1.5

30.5

1168

8304

R60.0

ICD-10 Finland

Localized oedema

1.6

30.5

853

5672

JFA52

NOMESCO Finland

Other endoscopic haemostatic procedure in colon

7.4

30.5

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.8

30.4

157

576

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

30.4

1850

14309

5568X

ICD-9 Finland

Idiopathic proctocolitis, Other ulcerative colitis

9.8

30.3

E66.8

ICD-10 Finland

Other obesity

2.0

30.2

330

1677

N06AA09

ATC

amitriptyline; systemic

1.7

30.0

583

3541

JHD00

NOMESCO Finland

Anal dilatation

11.5

30.0

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

30.0

688

4365

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.8

29.8

480

2766

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

29.7

3597

30811

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.6

29.7

176

692

E66.00

ICD-10 Finland

Metabolic syndrome

1.9

29.7

377

2017

JFG30

NOMESCO Finland

Closure of colostomy with resection of exteriorised loop

45.2

29.6

U05

ICPC

Urination problems other

1.9

29.6

364

1927

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

29.6

548

3287

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.1

29.5

301

1492

D25

ICPC

Abdominal distension

3.0

29.4

127

422

1490

FHL

Sigmoideoscopy (fiberscope)

9.8

29.4

L04AB04

ATC

adalimumab; parenteral

2.8

29.4

145

519

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.5

29.4

189

773

D09

ICPC

Nausea

2.3

29.3

235

1059

JG1JB

NOMESCO Finland

Defekography with X-ray

7.2

29.2

5650B

ICD-9 Finland

Anal fissure and fistula, Anal fissure[FISSURA ANI TYPICA]

+∞

29.2

JG1BG

NOMESCO Finland

MRI of rectum

4.4

29.1

164

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.1

29.1

282

1371

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.7

29.0

252

L05

ICPC

Flank/axilla symptom/complaint

1.8

28.8

417

2326

S04

ICPC

Lump/swelling localized

1.6

28.8

699

4494

ZXA10

NOMESCO Finland

Bilateral

1.5

28.8

1185

8537

B01AC04

ATC

clopidogrel; oral

1.5

28.8

1170

8409

N02BF01

ATC

gabapentin; oral

1.6

28.7

655

4147

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.2

28.7

245

1133

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

28.7

2751

22766

K22.7

ICD-10 Finland

Barrett oesophagus

3.4

28.7

104

311

K55.1

ICD-10 Finland

Chronic vascular disorders of intestine

150.6

28.6

E86

ICD-10 Finland

Volume depletion

2.5

28.6

175

699

L08

ICPC

Shoulder symptom/complaint

1.4

28.6

1514

11419

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.3

28.5

227

1020

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

28.5

616

3848

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

5.7

28.4

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.8

28.4

441

2513

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

28.4

342

1797

A07AA02

ATC

nystatin; oral

1.9

28.3

368

1984

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

28.2

617

3865

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.0

28.2

198

ZY010

NOMESCO Finland

Hospital outpatient

2.1

28.1

275

1342

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

28.1

729

4763

R01AD08

ATC

fluticasone; nasal

1.4

27.9

1674

12884

A07AA11

ATC

rifaximin; oral

7.0

27.9

A12AA04

ATC

calcium carbonate; oral

3.0

27.7

120

400

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.8

27.6

453

2623

Z94.4

ICD-10 Finland

Liver transplant status

6.9

27.5

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

27.5

1518

11520

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.7

27.5

143

527

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

5.3

27.4

105

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

27.3

893

6137

D17

ICPC

Incontinence of bowel

4.1

27.3

181

R13

ICD-10 Finland

Dysphagia

1.8

27.2

441

2545

M10.9

ICD-10 Finland

Gout, unspecified

1.7

27.2

512

3083

K63.4

ICD-10 Finland

Enteroptosis

+∞

27.1

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.3

27.1

213

953

N32.1

ICD-10 Finland

Vesicointestinal fistula

9.4

27.0

L04AX03

ATC

methotrexate; systemic

1.6

27.0

617

3906

R05

ICPC

Cough

1.4

27.0

1560

11924

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.9

27.0

350

1885

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.1

26.9

275

1363

H01

ICPC

Ear pain/earache

1.6

26.9

651

4179

V03AE02

ATC

sevelamer; oral

5.3

26.9

103

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

4.0

26.9

196

A41.8

ICD-10 Finland

Other specified sepsis

2.7

26.9

145

544

D29

ICPC

Digestive symptom/complaint other

2.6

26.9

155

602

-62

ICPC

Administrative procedure

2.4

26.8

184

776

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

26.7

216

978

XF402

NOMESCO Finland

ECG with work load test

1.6

26.7

685

4462

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.4

26.7

286

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.6

26.6

149

570

N06AB03

ATC

fluoxetine; oral

1.6

26.5

695

4547

L86

ICPC

Back syndrome with radiating pain

1.8

26.4

394

2218

TQW40

NOMESCO Finland

Remowal of suture of skin

1.7

26.3

477

2841

A07AA09

ATC

vancomycin; oral

3.3

26.3

100

308

D19

ICPC

Teeth/gum symptom/complaint

1.4

26.2

1878

14844

D91

ICPC

Abdominal hernia other

3.2

26.2

101

314

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.8

26.2

135

495

JWC00

NOMESCO Finland

Reoperation for deep infection in gastroenterological surgery

25.8

26.1

G04BD12

ATC

mirabegron; oral

1.5

26.1

784

5291

SPAT1254

SPAT

Administration of medicine

1.5

26.1

882

6104

4553A

ICD-9 Finland

Haemorrhoids, External haemorrhoids without mention of complication

+∞

26.0

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.6

25.9

626

4016

C18.51

ICD-10 Finland

Malignant tumor of flexura hiealis invasive carcinoma

9.7

25.9

253, ,

Kela drug reimbursment

9.7

25.9

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.5

25.7

759

5101

K55.9

ICD-10 Finland

Vascular disorder of intestine, unspecified

93.7

25.6

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.8

25.6

437

2559

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.7

25.6

524

3225

TK810

NOMESCO Finland

Hemofiltration

4.5

25.6

135

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.9

25.5

303

1585

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.6

25.5

616

3953

R5599

NOMESCO Finland

Other rehabilitation service

2.3

25.5

190

831

WX110, ,

SPAT

1.9

25.4

345

1886

5561A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis

7.3

25.4

A03

ICPC

Fever

1.5

25.4

930

6539

M01AE02

ATC

naproxen; oral, rectal

1.3

25.3

3553

30778

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

25.3

1800

14198

3042, ,

Kela drug reimbursment

9.4

25.3

A46

ICD-10 Finland

Erysipelas

1.5

25.2

1031

7403

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

3.7

25.2

210

D15

ICPC

Melaena

6.3

25.2

K57.5

ICD-10 Finland

Diverticular disease of both small and large intestine without perforation or abscess

25.1

25.2

R5110, ,

SPAT

1.6

25.2

594

3789

Y84.8

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.0

25.2

179

JFF26

NOMESCO Finland

Sigmoidostomy

22.6

25.1

Z00.8

ICD-10 Finland

Other general examinations

1.7

25.1

487

2955

JHB00

NOMESCO Finland

Hemorrhoidectomy

2.5

25.1

162

664

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

4.1

25.0

171

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

8.9

25.0

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

25.0

205

933

56419

ICD-8 Finland

Functional disorders of intestines, Colon irritabile aliud sive NUD

+∞

25.0

5621A

ICD-9 Finland

Diverticula of intestine, Colon[DIVERTICULOSIS COLI]

+∞

25.0

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

24.9

2337

19181

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

24.9

1276

9542

L12

ICPC

Hand/finger symptom/complaint

1.4

24.8

1049

7580

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

3.9

24.8

190

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.9

24.7

303

1602

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.1

24.7

250

1236

J45

ICD-10 Finland

Asthma

1.6

24.7

610

3935

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

24.7

554

3491

I84

ICD-10 Finland

Hemorrhoids

2.6

24.5

141

547

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.9

24.5

324

1757

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

2.4

24.5

171

727

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

2.9

24.5

111

380

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

24.5

608

3927

M54

ICD-10 Finland

Dorsalgia

1.6

24.4

679

4501

SPAT1263

SPAT

Sampling

1.3

24.4

2525

20989

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.1

24.4

238

1161

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

24.3

482

2941

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.7

24.3

454

2726

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

2.8

24.2

121

437

L14

ICPC

Leg/thigh symptom/complaint

1.7

24.1

513

3189

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.9

24.1

321

1745

L04

ICPC

Chest symptom/complaint

1.8

24.1

393

2273

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.0

24.0

264

1345

56901

ICD-8 Finland

Other diseases of intestines and peritoneum, Perforatio intestini NUD

+∞

24.0

-60

ICPC

Result test/procedure

1.8

23.9

357

2011

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.6

23.9

133

508

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

23.9

378

2167

JHD10

NOMESCO Finland

Myotomy of anal sphincter

67.6

23.8

J01DA06

ATC

[U] cefuroxime

1.5

23.8

848

5926

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

23.8

510

3177

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.3

23.8

189

850

R33

ICD-10 Finland

Retention of urine

1.6

23.8

518

3240

J01FA09

ATC

clarithromycin; systemic

1.3

23.7

1859

14852

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

23.7

590

3811

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.3

23.7

186

832

N17

ICPC

Vertigo/dizziness

1.5

23.7

792

5463

K57.4

ICD-10 Finland

Diverticular disease of both small and large intestine with perforation and abscess

240.7

23.6

K60.4

ICD-10 Finland

Rectal fistula

240.7

23.6

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.0

23.6

277

1444

R21

ICPC

Throat symptom/complaint

1.4

23.6

1023

7423

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

4.4

23.5

132

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

23.5

2861

24258

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.7

23.5

127

478

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.0

23.4

254

1287

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.8

23.3

368

2107

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

6.8

23.3

L13

ICPC

Hip symptom/complaint

1.4

23.3

1257

9473

R83

ICPC

Respiratory infection other

1.4

23.2

1291

9780

N06AB10

ATC

escitalopram; oral

1.4

23.1

1067

7826

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

23.1

4646

41890

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

23.1

1876

15060

C09CA06

ATC

candesartan; oral

1.3

23.1

1586

12422

6101

FHL

Exploratory laparotomy, includes possible biopases

6.4

23.0

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

22.9

2344

19417

M01AH05

ATC

etoricoxib; oral

1.3

22.9

4107

36497

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

4.6

22.8

115

K58

ICD-10 Finland

Irritable bowel syndrome

2.8

22.8

117

429

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

8.6

22.7

K29.8

ICD-10 Finland

Duodenitis

3.9

22.7

166

JFG29

NOMESCO Finland

Closure of terminal enterostomy with anastomosis to rectum

230.7

22.6

A07EA01

ATC

prednisolone; oral, rectal

5.2

22.6

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

2.1

22.6

211

1012

R55

ICD-10 Finland

Syncope and collapse

1.5

22.6

714

4864

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

4.5

22.6

120

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.0

22.5

234

1168

E87.5

ICD-10 Finland

Hyperkalaemia

2.6

22.5

133

523

XQ855

NOMESCO Finland

Skin temperature measurement

5.6

22.5

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

22.5

408

2430

XG466

NOMESCO Finland

Sleep oxymetry

2.2

22.5

198

928

XKD00

NOMESCO Finland

Uroflowmetry

1.4

22.4

1053

7747

C10AA05

ATC

atorvastatin; oral

1.3

22.4

3076

26432

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.9

22.3

297

1613

A10AE04

ATC

insulin glargine; parenteral

1.5

22.3

645

4310

R03AK08

ATC

formoterol and beclometasone; inhalant

1.9

22.3

274

1450

EB1AA, ,

SPAT

1.7

22.3

389

2293

RS221, ,

NOMESCO Finland

3.0

22.2

325

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.0

22.2

100

341

JN2AD

NOMESCO Finland

CT examination of lower part of abdomen

5.8

22.2

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.7

22.2

404

2410

JAG60

NOMESCO Finland

Reconstruction of abdominal wall using prosthetic material

7.9

22.1

K65.8

ICD-10 Finland

Other peritonitis

7.9

22.1

K64.4

ICD-10 Finland

Residual haemorrhoidal skin tags

7.9

22.1

J46

ICD-10 Finland

Status asthmaticus

2.3

22.1

176

792

M02AA07

ATC

piroxicam; topical

1.3

22.1

2296

19035

N19

ICD-10 Finland

Unspecified kidney failure

2.0

22.1

254

1315

JJC00

NOMESCO Finland

Allogenic transplantation of liver

7.6

22.1

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

1.8

22.0

308

1701

J01XX08

ATC

linezolid; systemic

4.1

22.0

148

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.7

21.9

384

2265

RD210, ,

NOMESCO Finland

2.8

21.9

109

393

56510

ICD-8 Finland

Anal fissure and fistula, Anal fistula

+∞

21.9

Z50.1

ICD-10 Finland

Other physical therapy

1.8

21.9

326

1835

JFG50

NOMESCO Finland

Laparotomy with revision of enterostomy or colostomy

62.7

21.8

D07AB08

ATC

desonide; topical

1.5

21.8

629

4201

Z53.8

ICD-10 Finland

Procedure not carried out for other reasons

5.0

21.8

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

21.8

834

5905

ZX100

NOMESCO Finland

Oral

2.9

21.7

101

351

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

3.6

21.7

199

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.2

21.7

188

876

R19.5

ICD-10 Finland

Other faecal abnormalities

3.0

21.7

309

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

4.1

21.6

141

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.9

21.6

256

1338

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.3

21.6

157

680

D07AC01

ATC

betamethasone; topical

1.3

21.5

2331

19413

A01AB09

ATC

miconazole; local oral

1.6

21.5

487

3073

R06AX22

ATC

ebastine; oral

1.4

21.5

942

6839

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.5

21.5

138

565

S22

ICPC

Nail symptom/complaint

1.7

21.5

426

2599

A98

ICPC

Health maint/preventive medicine

1.5

21.5

7011

67366

N05CD07

ATC

temazepam; oral

1.5

21.5

709

4874

C09CA01

ATC

losartan; oral

1.3

21.3

1778

14298

A02BA04

ATC

nizatidine; systemic

1.7

21.3

443

2738

B37.7

ICD-10 Finland

Candidal sepsis

7.5

21.2

A02BC04

ATC

rabeprazole; oral

1.6

21.1

484

3063

SFA10

NOMESCO Finland

One-surface restoration

1.3

21.1

3449

30185

K92.0

ICD-10 Finland

Haematemesis

2.3

21.0

154

669

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

21.0

925

6721

P06

ICPC

Sleep disturbance

1.5

21.0

719

4979

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.9

21.0

276

1495

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

20.9

1292

9934

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

20.9

680

4658

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

6.4

20.9

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

6.4

20.9

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

4.1

20.8

141

N18.0

ICD-10 Finland

End-stage renal disease

3.3

20.8

244

A10BA02

ATC

metformin; oral

1.3

20.8

1957

15989

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

20.8

655

4458

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.7

20.8

367

2171

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1736

6743

3.04

322.70

5.1

4.4

16.00

35.03

ug/l

2.05

1405

5578

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2974

15373

2.54

314.69

3.7

2.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4455

27683

2.48

314.38

4.7

2.8

134.96

150.52

ug/l

1.83

4215

25641

(3019069) Monocytes/Leukocytes in Blood

4691

29947

2.49

310.19

9.1

6.3

9.00

8.99

0.02

4480

27976

(3022096) Basophils/Leukocytes in Blood

4681

29903

2.48

308.29

9.0

6.3

0.66

0.68

1.71

4477

27893

(3006504) Eosinophils/Leukocytes in Blood

4677

29875

2.48

307.94

9.0

6.2

2.73

2.87

3.52

4465

27901

(3033658) Prothrombin time (PT) actual/Normal

3185

16585

2.59

307.65

7.0

3.9

87.23

88.35

1.66

3132

16228

(3023368) Bacteria identified in Blood by Culture

3397

18447

2.53

307.65

6.3

4.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

2537

10874

3.00

307.65

3.7

2.5

11.29

13.14

umol/l

31.64

2407

10110

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1336

3880

3.97

307.65

1.9

1.6

—

(3022145) Colonoscopy Study observation

3199

5073

10.19

307.65

1.6

1.4

—

(40768797) Stomach Pathology biopsy report

2064

7684

3.32

307.65

1.4

1.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3267

15974

2.84

307.65

3.4

2.2

2.83

2.80

mg/l

0.27

2940

13697

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5381

33709

3.06

307.65

9.7

6.7

11.55

12.15

umol/l

2.58

5228

32112

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2419

10179

3.02

307.65

3.6

2.5

2.32

2.28

g/l

3.02

2281

9402

(3024561) Albumin [Mass/volume] in Serum or Plasma

4904

29619

2.86

307.65

9.4

4.8

34.34

35.41

g/l

28.18

4725

27607

(3048689) Calprotectin [Mass/mass] in Stool

1808

5483

4.02

307.65

3.2

2.1

178.09

129.60

ug/g

5.13

1532

4341

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3477

18932

2.55

307.65

4.0

2.5

60.26

64.67

u/l

0.66

3301

17432

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1554

5569

3.25

307.65

3.3

2.3

55.28

52.43

u/l

0.06

1364

4707

(3044640) Blood type and Crossmatch panel - Blood

3663

20341

2.55

307.65

3.7

2.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2306

9402

3.09

307.65

3.7

2.5

19.82

23.13

21.75

2196

8723

(3013650) Neutrophils [#/volume] in Blood by Automated count

5333

36371

2.58

301.29

13.2

9.4

4.41

4.16

e9/l

10.95

4581

31147

(3002030) Lymphocytes/Leukocytes in Blood

4738

30651

2.46

299.96

9.0

6.3

25.37

27.15

24.14

4555

28911

(3018010) Neutrophils/Leukocytes in Blood

4650

29957

2.43

295.16

8.8

6.1

59.39

57.69

18.47

4497

28560

(3042936) Bacteria identified in Isolate by Culture

2029

9145

2.66

280.12

2.8

2.0

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1692

7064

2.80

270.51

3.9

2.7

7.31

9.64

umol/l

4.78

1519

6229

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6481

50153

3.03

258.65

13.6

7.9

84.15

80.55

u/l

5.84

6307

47419

(3032080) INR in Blood by Coagulation assay

4711

31536

2.31

258.63

19.6

15.4

1.29

1.28

inr

0.16

3978

26270

(3006315) Basophils [#/volume] in Blood

4818

32635

2.31

255.94

8.8

6.0

0.04

e9/l

0.41

4099

27590

(3001604) Monocytes [#/volume] in Blood

4803

32549

2.30

253.98

8.8

6.0

0.63

0.60

e9/l

7.64

4092

27503

(3013115) Eosinophils [#/volume] in Blood

4909

33599

2.31

253.04

9.2

6.2

0.19

0.20

e9/l

1.96

4251

28952

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4499

29778

2.26

250.48

4.2

2.7

—

estimate

—

(3019198) Lymphocytes [#/volume] in Blood

4860

33297

2.28

247.30

8.9

6.0

1.78

1.90

e9/l

7.34

4228

28888

(3000991) Gas panel - Venous blood

1437

5758

2.85

246.28

14.8

9.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1497

6209

2.76

239.63

3.3

2.1

0.21

g/l

0.05

1409

5780

(3007164) IgA [Mass/volume] in Serum or Plasma

2152

10652

2.43

238.04

1.7

1.5

2.61

2.55

g/l

0.61

1262

6560

(3027945) Reticulocytes/Erythrocytes in Blood

1720

7704

2.59

235.59

2.7

2.5

1.85

1.78

2.17

1570

6871

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2439

12857

2.32

232.65

5.3

3.8

336.48

527.46

ng/l

1.30

1989

10552

(3020779) Urea [Moles/volume] in Serum or Plasma

1467

6116

2.73

231.80

10.7

7.1

10.45

10.12

mmol/l

0.92

1425

5849

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4871

33932

2.22

230.16

12.5

7.1

1.20

1.21

mmol/l

18.47

4343

29157

(3002582) Erythrocytes [#/volume] in Urine

3512

21545

2.17

229.78

4.7

3.2

71.22

79.83

e6/l

0.21

2692

16258

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2210

11286

2.35

225.88

5.3

3.3

0.80

0.82

mmol/l

4.27

2117

10622

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1855

8772

2.48

225.25

9.7

5.8

1.06

1.03

mmol/l

3.36

1775

8168

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

3741

23646

2.15

225.16

4.7

3.3

—

1.03

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3428

20978

2.16

224.04

4.6

3.2

36.55

35.37

u/l

0.15

3261

19723

(3013826) Glucose [Moles/volume] in Serum or Plasma

5342

38903

2.27

221.97

9.3

4.9

6.84

6.82

mmol/l

0.23

5201

36993

(3018095) Leukocytes [#/volume] in Urine

3794

24240

2.13

220.50

5.7

3.7

117.68

109.78

e6/l

0.19

2785

16963

(3030467) Casts [#/volume] in Urine by Automated count

3127

18583

2.16

219.11

4.6

3.1

0.48

0.46

e6/l

0.12

2291

13452

(3014111) Lactate [Moles/volume] in Serum or Plasma

1410

5939

2.69

217.11

12.6

8.0

1.33

1.36

mmol/l

0.48

1391

5817

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4367

29537

2.13

217.11

2.6

2.1

91.70

95.44

pmol/l

6.08

2507

15472

(3000570) Elastase.pancreatic [Mass/mass] in Stool

580

1429

4.31

212.65

1.5

1.4

259.93

269.56

ug/g

0.47

386

867

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2067

10527

2.33

210.31

4.0

3.0

2.88

2.21

e6/l

1.89

1019

5037

(40768804) Tissue Pathology biopsy report

3880

25341

2.09

208.72

2.6

2.1

—

(36304419) Bacteria [Presence] in Urine

2962

17599

2.12

203.98

4.5

3.1

0.00

33.93

estimate

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2246

12038

2.23

200.63

1.4

1.3

2.13

2.04

u/ml

0.08

485

3291

(3023520) Reticulocytes [#/volume] in Blood

1382

6000

2.59

198.65

2.7

2.6

70.36

69.08

e9/l

0.59

956

4391

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1103

4344

2.80

191.91

13.2

8.5

24.59

24.81

mmol/l

1.23

1097

4315

(3021960) Folate [Moles/volume] in Serum or Plasma

3076

18998

2.04

186.51

2.0

1.6

20.67

19.98

nmol/l

1.73

2719

16014

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1043

4064

2.82

184.79

14.2

9.9

23.99

24.32

mmol/l

2.76

1024

3976

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4344

30366

2.01

184.68

12.0

6.4

1.20

1.21

mmol/l

13.71

4123

28045

(3031040) Bacteria [#/volume] in Urine by Automated count

5460

41584

2.12

181.01

6.4

4.3

1149.69

1862.05

e6/l

0.77

649

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1019

3979

2.80

179.52

14.7

10.2

15.35

16.11

14.21

1003

3821

(3037467) Urinalysis macro (dipstick) panel - Urine

5634

43489

2.15

179.27

6.2

4.2

2.42

2.45

0.01

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2122

11596

2.15

176.84

4.0

2.9

1.01

1.32

e6/l

0.56

1105

6135

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2053

11118

2.16

174.80

2.2

1.9

—

(3019977) pH of Arterial blood

1629

8103

2.29

170.63

13.0

7.8

7.41

7.42

1.25

712

4482

(3016502) Oxygen saturation in Arterial blood

1487

7180

2.33

166.65

13.4

8.1

95.93

95.52

1.63

1448

6921

(3003396) Base excess in Arterial blood by calculation

1607

8037

2.27

165.61

12.9

7.7

0.46

1.02

mmol/l

6.20

1389

6645

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1618

8116

2.26

165.55

13.0

7.8

5.08

5.11

kpa

0.49

1568

7802

(3027801) Oxygen [Partial pressure] in Arterial blood

1617

8113

2.26

165.32

13.0

7.8

12.60

12.25

kpa

1.88

1569

7793

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

5939

47410

2.17

163.78

6.2

4.2

14.72

12.70

mm/h

17.84

5646

44172

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

817

2990

2.94

161.55

1.8

1.6

1.61

1.56

g/l

0.75

722

2552

(3012544) pH of Venous blood

1414

6768

2.34

161.21

6.9

3.7

7.37

7.38

1.48

790

3923

(3002032) Base excess in Venous blood by calculation

1367

6470

2.36

159.82

6.9

3.8

1.53

1.83

mmol/l

2.09

1207

5639

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1566

7913

2.23

156.42

4.1

4.6

233.41

249.43

u/l

4.46

1494

7546

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1391

6708

2.32

155.31

14.4

8.6

115.72

121.88

g/l

23.22

1370

6539

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

934

3751

2.70

154.61

7.1

3.9

24.05

24.22

mmol/l

0.88

927

3710

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1378

6676

2.30

151.89

6.9

3.7

5.77

5.82

kpa

1.02

1344

6521

(3018418) pH of Serum or Plasma

3118

20477

1.89

148.41

6.6

4.1

7.40

0.10

2245

14587

(3000850) Epithelial cells [#/volume] in Urine

2420

14737

1.94

144.05

3.6

2.6

4.81

5.26

e6/l

1.03

2225

13387

(3015377) Calcium [Moles/volume] in Serum or Plasma

3359

23000

1.83

136.47

4.7

3.6

2.34

2.36

mmol/l

5.79

3129

20914

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3999

29001

1.80

132.91

3.2

2.3

77.02

78.24

nmol/l

1.89

3689

26100

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2230

13508

1.92

132.80

2.1

1.7

1.42

1.32

mg/l

0.66

1802

10587

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5245

41303

1.88

132.68

5.0

3.2

63.17

51.99

u/l

9.92

5007

38472

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

657

2398

2.90

129.56

4.4

3.7

444.67

2333.15

u/ml

1.04

563

2082

(3026008) Bacteria identified in Urine by Culture

2911

19321

1.82

128.98

4.1

3.0

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1002

4531

2.40

127.87

15.3

9.8

1.24

1.33

2.62

997

4505

(3026782) Osmolality of Urine

2081

12450

1.93

127.80

3.6

2.8

532.80

539.39

mosm/kgh2o

0.58

1845

10868

(3003327) Ova and parasites identified in Stool by Light microscopy

493

1539

3.36

127.01

1.7

1.6

—

(40758558) Short blood count panel - Blood

2955

19822

1.80

125.48

8.7

6.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3083

20982

1.79

124.37

3.8

3.1

1824.82

1445.60

ng/l

2.99

2715

18163

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

479

1492

3.36

123.79

1.4

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

725

2854

2.70

123.67

2.6

2.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

516

1687

3.21

123.19

1.4

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

618

2254

2.90

121.82

3.6

2.9

0.32

0.35

iu/ml

1.85

316

1245

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1527

8341

2.04

121.10

2.1

1.8

—

(3024928) Oxygen saturation in Venous blood

497

1619

3.21

119.31

4.9

3.1

63.03

61.88

0.48

486

1572

(3007853) Bacteria identified in Skin by Aerobe culture

1385

7340

2.09

119.06

2.1

1.8

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1793

10465

1.93

117.02

2.7

2.0

30.34

29.75

3.61

1763

10189

(3028026) IgM [Mass/volume] in Serum or Plasma

831

3628

2.45

113.97

2.0

1.9

1.25

1.35

g/l

0.71

780

3307

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

334

864

4.00

113.69

7.9

5.9

12.53

11.74

mg/l

2.09

310

799

(3005719) IgG [Mass/volume] in Serum or Plasma

992

4687

2.28

113.57

3.2

2.8

10.49

10.65

g/l

0.50

922

4325

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2135

13341

1.84

111.81

3.9

3.0

2.47

2.46

mmol/l

3.77

1941

11988

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1428

7837

2.01

110.71

2.1

1.8

—

(36660697) Celiac disease serology panel - Serum

902

4192

2.31

107.02

1.2

—

(3002256) Pathology report gross observation

1533

8733

1.95

106.24

1.4

1.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

865

3968

2.33

105.74

1.9

1.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7006

62719

2.56

104.18

32.7

15.1

31.71

25.61

mg/l

37.30

6370

51207

(3017143) Hepatitis C virus Ab [Presence] in Serum

1138

5915

2.09

101.67

2.0

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

2575

17413

1.73

100.62

3.4

2.8

0.15

0.04

0.97

448

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1065

5446

2.11

99.18

3.4

2.9

217.87

195.44

ng/l

0.95

974

5007

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

496

1793

2.89

98.91

3.2

2.5

3.73

3.62

g/l

0.74

479

1714

(3026493) Urate [Moles/volume] in Serum or Plasma

2636

18009

1.71

98.79

3.6

2.7

357.25

348.09

umol/l

4.38

2352

15822

(46235355) HIV 1 and 2 tests - Meaningful Use set

1416

8046

1.93

98.01

2.1

1.7

—

(3037522) Nuclear Ab [Titer] in Serum

1463

8420

1.91

97.37

1.5

1.3

514.01

477.48

titre

0.33

327

1822

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

472

1688

2.92

95.94

3.1

2.5

209.83

198.44

1.63

450

1613

(3019309) Folate [Moles/volume] in Red Blood Cells

1786

11095

1.80

92.50

1.9

1.7

1099.68

1170.25

nmol/l

2.69

1412

8420

(3021589) Normoblasts [#/volume] in Blood

3825

29162

1.63

91.28

18.5

11.1

0.00

e9/l

0.08

3029

23667

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1262

7061

1.94

90.79

1.9

1.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

491

1855

2.76

89.96

2.8

2.2

88.79

92.00

1.95

477

1786

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

970

4958

2.10

89.87

6.3

3.7

111.97

90.91

ng/l

3.99

865

4222

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

639

2747

2.45

89.84

2.4

2.3

3.67

3.74

g/l

0.58

605

2503

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

616

2605

2.49

89.75

2.4

2.3

2.99

2.91

g/l

1.13

583

2362

(3025941) Bacteria identified in Stool by Culture

615

2604

2.48

89.35

1.4

1.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

639

2754

2.44

89.33

2.4

2.3

4.18

4.21

g/l

0.41

605

2512

(3052851) Hemolysis interference index of Serum or Plasma

460

1686

2.84

89.25

3.7

3.3

2.26

2.24

index

0.01

251

847

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

639

2757

2.44

89.11

2.4

2.3

7.46

7.39

g/l

0.45

605

2512

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2939

21120

1.64

88.05

2.5

2.2

211.02

228.69

u/l

0.46

2807

19912

(3036489) Thrombin time

560

2289

2.56

87.62

2.5

2.0

21.16

21.06

0.15

518

2032

(3024354) Oxygen [Partial pressure] in Venous blood

1041

5526

2.02

86.81

5.4

3.1

4.87

4.51

kpa

3.86

1015

5386

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

449

1665

2.80

85.17

1.5

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1043

5595

2.00

84.28

2.7

2.5

375.18

385.36

nmol/l

0.63

983

5206

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

492

1928

2.66

83.81

1.6

21.47

18.74

u/ml

0.31

451

(3000494) Fungus identified in Specimen by Culture

1321

7689

1.87

83.58

1.8

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

239

615

3.98

81.82

1.5

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

561

2372

2.47

81.56

2.4

2.3

9.81

10.16

g/l

1.16

522

2104

(3007566) Smooth muscle Ab [Titer] in Serum

441

1667

2.75

80.57

1.3

1.2

108.25

154.80

titre

0.45

152

(3034770) Mitochondria Ab [Titer] in Serum

436

1657

2.73

78.81

1.3

1.2

416.25

945.34

titre

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

239

632

3.87

78.75

1.5

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1050

5778

1.95

78.42

2.6

64.88

66.32

g/l

7.35

1000

5285

(3024522) Salmonella sp identified in Specimen by Organism specific culture

232

619

3.83

75.47

1.5

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

524

2224

2.46

75.42

2.3

1.8

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

493

2038

2.52

75.08

2.5

2.3

0.03

0.02

g/l

0.18

462

1832

(4035726) Immunohistochemistry procedure

1072

6064

1.89

73.32

1.5

1.4

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

453

1819

2.59

73.27

1.4

3.66

17.65

iu/ml

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4269

34422

1.55

72.87

3.0

2.6

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

453

1836

2.56

71.85

2.5

2.3

0.00

g/l

-0.00

434

1717

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

469

1935

2.52

71.66

2.2

1.7

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

544

2415

2.35

70.71

2.5

2.4

0.64

0.84

g/l

0.80

498

2063

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

545

2424

2.35

70.53

2.4

2.0

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

470

1980

2.46

68.62

2.4

2.3

0.00

g/l

0.50

436

1720

(3005988) Vibrio sp identified in Specimen by Organism specific culture

217

596

3.72

67.69

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

217

596

3.72

67.69

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

354

1309

2.79

67.32

8.2

5.6

353.15

1574.21

iu/ml

0.54

194

(3025468) Yersinia sp identified in Specimen by Organism specific culture

215

595

3.69

66.33

1.5

1.4

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

6754

61467

1.91

66.00

31.1

15.4

77.94

78.43

ml/min/173m2

1.11

6432

57073

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

435

1808

2.49

65.34

1.7

1.5

0.14

2.87

iu/ml

0.85

351

(3021879) Hepatitis B virus core Ab [Presence] in Serum

776

4099

2.00

64.54

1.6

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

783

4150

1.99

64.50

5.3

3.2

122.88

129.43

g/l

10.73

754

4042

(3014765) Yersinia sp identified in Stool by Organism specific culture

343

1282

2.75

63.88

1.3

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

7083

65671

2.21

63.86

37.9

18.4

139.39

139.77

mmol/l

29.10

7023

64345

(42529406) Shigella sp [Presence] in Stool by Culture

343

1286

2.75

63.50

1.4

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6501

58630

1.77

63.38

6.3

5.1

1.90

1.97

mu/l

3.56

6102

53838

(3023103) Potassium [Moles/volume] in Serum or Plasma

7088

65829

2.20

62.06

38.5

18.6

3.96

3.99

mmol/l

12.05

7025

64377

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

811

4406

1.94

62.05

5.0

3.6

5.09

5.16

kpa

1.51

785

4206

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

338

1274

2.73

61.92

1.3

1.1

—

(3003694) ABO and Rh group [Type] in Blood

2452

17986

1.54

61.31

1.5

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

511

2351

2.26

60.88

2.8

3.4

148.44

55.34

mg/l

0.50

435

1988

(3009445) Proteinase 3 Ab [Units/volume] in Serum

575

2795

2.14

59.72

1.5

1.7

3.33

16.74

iu/ml

3.16

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

508

2350

2.25

59.71

2.8

3.4

42.02

43.61

mg/l

0.10

432

1988

(3023183) Ammonium ion [Moles/volume] in Plasma

366

1463

2.58

59.61

4.1

2.5

35.19

33.34

umol/l

0.79

341

1322

(3013005) Retinol [Moles/volume] in Serum or Plasma

110

194

5.74

59.44

3.3

1.4

1.91

1.95

umol/l

0.13

104

178

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

329

1250

2.71

59.33

1.4

1.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

505

2361

2.22

57.80

3.5

3.0

24.34

24.84

mmol/l

1.84

498

2323

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

463

2089

2.30

57.73

2.8

3.3

8.16

6.57

ratio

0.12

246

1192

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

969

5707

1.80

57.24

2.8

2.3

7.98

8.46

ug/l

0.26

889

5048

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5535

48365

1.54

56.87

4.9

4.2

14.75

14.89

pmol/l

3.73

5142

44208

(3009343) pH of Capillary blood

776

4272

1.91

56.83

5.0

3.6

7.41

7.42

0.58

678

3555

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

509

2424

2.18

55.61

2.7

2.2

644.48

713.78

ug/l

0.15

492

2305

(3009261) Glucose [Presence] in Urine by Test strip

4163

34471

1.46

54.91

4.8

3.7

0.03

0.36

estimate

0.91

847

6755

(3024980) IgG subclass 4 [Mass/volume] in Serum

270

971

2.85

54.05

1.6

0.78

0.90

g/l

0.95

202

738

(3028626) Oxygen [Partial pressure] in Capillary blood

389

1680

2.39

53.59

4.9

3.3

8.33

8.02

kpa

1.69

380

1642

(3015736) pH of Urine

3372

26906

1.46

53.50

4.0

3.3

6.10

6.21

6.93

1692

14752

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

280

1037

2.77

53.03

1.4

1.3

259.47

278.20

u/ml

0.45

172

644

(44816559) Phosphatidylethanol [Mass/volume] in Blood

490

2348

2.16

52.65

1.9

1.6

0.35

0.32

mg/l

0.63

256

1116

(3047181) Lactate [Moles/volume] in Blood

437

2002

2.26

52.47

9.6

5.8

1.35

1.36

mmol/l

0.09

391

1772

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1113

6994

1.69

51.90

4.7

3.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

545

2735

2.07

51.87

2.5

1.9

3.03

2.17

ug/l

0.62

491

2429

(3013139) Helicobacter pylori Ag [Presence] in Stool

692

3798

1.90

50.92

1.3

1.2

—

(3042733) HLA Ab [Presence] in Serum

176

5.57

50.89

5.4

4.6

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

485

2347

2.14

50.78

1.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

4066

33842

1.43

50.03

4.7

3.6

0.00

estimate

0.70

878

7056

(3035350) Ketones [Presence] in Urine by Test strip

4102

34253

1.43

49.22

4.8

3.7

10.52

3.13

estimate

1.00

903

7261

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

675

3732

1.89

48.47

4.9

3.4

1.94

1.96

mmol/l

0.04

495

2740

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

473

2308

2.12

48.43

1.1

1.0

—

(3009508) Creatinine [Moles/volume] in Urine

3093

24681

1.43

46.96

4.3

3.4

7.35

7.61

mmol/l

2.77

2669

20714

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

289

1156

2.56

46.95

1.7

1.5

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

267

1032

2.65

46.51

4.0

2.7

430.38

1695.76

u/ml

0.98

(3048929) Epstein Barr virus Ab [Presence] in Serum

347

1521

2.34

46.17

1.4

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

335

1446

2.38

46.16

1.6

1.7

—

(3026250) Tacrolimus [Mass/volume] in Blood

112

253

4.48

45.60

47.3

38.3

7.17

7.25

ug/l

0.13

100

232

(3011397) Hemoglobin [Presence] in Urine by Test strip

2101

15669

1.47

45.46

4.1

3.6

0.13

0.15

—

174

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7109

67027

1.99

45.01

19.8

11.8

26.88

26.54

u/l

0.59

7021

64852

(3020682) Albumin/Creatinine [Ratio] in Urine

3035

24276

1.42

44.79

5.0

4.1

12.11

8.25

mg/mmol

4.41

2094

15109

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1068

6893

1.64

44.36

1.9

1.7

1.58

1.50

2.33

915

5977

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

236

886

2.72

43.55

3.1

2.7

545.62

650.76

u/ml

0.06

236

878

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

112

264

4.29

43.20

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

137

374

3.71

43.19

1.4

1.3

33.40

23.56

u/l

0.76

113

308

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

139

384

3.67

43.06

1.4

1.3

113.65

87.64

u/l

1.03

118

321

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

380

1789

2.18

42.58

1.7

1.6

0.24

g/l

0.45

365

1697

(3012516) Albumin [Mass/volume] in Urine

2977

23880

1.41

42.54

4.3

3.4

63.77

46.13

mg/l

4.00

2135

15287

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

112

269

4.21

42.16

1.2

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

7153

67763

2.00

41.91

40.1

20.5

84.43

79.16

umol/l

16.32

7112

66935

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

305

1321

2.36

41.69

1.6

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

193

667

2.94

41.57

1.3

1.2

76.00

64.53

u/l

0.25

169

576

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3116

25276

1.40

41.31

4.9

3.6

47.46

77.69

ng/l

0.97

2324

18514

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1560

11140

1.50

41.25

1.4

1.3

32.57

37.05

iu/ml

0.59

462

3454

(3049717) Cytology report of Urine Cyto stain

492

2582

1.97

41.13

2.8

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

290

1236

2.40

41.10

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

290

1236

2.40

41.10

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

221

4.53

40.94

3.2

2.6

0.59

0.62

mmol/l

1.44

221

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

385

1860

2.13

40.37

1.8

1.5

1.20

g/l

0.04

372

1770

(3030981) Hyaline casts [#/volume] in Urine by Automated count

875

5498

1.67

40.11

3.0

2.4

0.50

0.47

e6/l

0.16

848

5274

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

257

1048

2.50

40.10

1.8

1.5

158.43

151.29

au/ml

0.44

331

(3021901) Oxygen saturation in Capillary blood

323

1460

2.27

39.97

3.7

3.0

89.67

89.56

0.10

314

1420

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1462

10369

1.51

39.77

1.4

1.3

11.88

13.42

u/ml

0.16

476

4016

(3002179) Metamyelocytes/Leukocytes in Blood

905

5755

1.65

39.56

4.4

4.2

0.58

0.74

1.57

381

1702

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

153

480

3.23

38.93

1.2

160.00

187.20

titre

0.16

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

352

1687

2.14

37.67

1.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

616

3571

1.79

37.65

1.5

1.3

336.82

272.24

u/ml

0.34

581

3291

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

133

391

3.44

37.55

1.3

1.2

91.29

78.82

—

(3037756) Immunofixation for Serum or Plasma

312

1440

2.22

36.70

1.6

1.7

—

(3017181) Myelocytes/Leukocytes in Blood

928

6051

1.61

36.48

4.7

4.3

0.90

1.01

0.65

381

1797

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

154

505

3.09

36.40

1.4

1.2

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

5763

52327

1.42

35.83

39.8

18.9

14.12

13.67

90.30

5729

51563

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

210

824

2.59

35.52

1.1

1.56

1.52

g/l

0.75

195

740

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

396

2027

2.01

35.49

5.8

3.1

1.77

1.56

mg/l

4.32

370

1824

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

488

2689

1.87

35.13

2.0

1.9

38.23

38.95

u/l

0.35

427

2366

(40760892) CBC W Ordered Manual Differential panel - Blood

1823

13790

1.42

34.84

5.9

4.6

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

299

1391

2.20

34.49

3.9

3.6

664.40

1226.62

u/ml

0.42

270

1280

(3051611) Lipemic interference index of Serum or Plasma

174

634

2.79

34.05

4.5

3.3

13.92

13.00

index

0.47

331

(3022313) Gas panel - Capillary blood

516

2945

1.81

33.14

5.3

3.7

—

(3020961) Endomysium IgA Ab [Titer] in Serum

432

2332

1.90

33.12

1.1

79.17

166.73

titre

2.21

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6550

61190

1.52

32.93

8.1

6.6

40.01

39.74

mmol/mol

1.67

6226

56961

(3021440) Promyelocytes/Leukocytes in Blood

880

5799

1.59

32.89

4.7

4.3

0.10

0.13

0.79

336

1556

(3004716) Salmonella sp identified in Stool by Organism specific culture

412

2197

1.93

32.77

1.4

—

(3019060) Gas panel - Arterial blood

674

4187

1.67

31.96

8.0

4.7

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

234

1019

2.34

31.62

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

12.45

31.48

2.7

3.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

205

4.13

31.05

1.1

1.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

250

3.79

30.87

35.4

27.9

122.67

111.52

ug/l

0.81

209

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

121

383

3.19

30.42

2.0

1.7

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

5719

52319

1.38

30.34

39.8

19.8

330.12

332.30

g/l

56.89

5699

52033

(3007461) Platelets [#/volume] in Blood

7172

68698

1.83

30.29

47.1

23.2

253.70

246.50

e9/l

14.16

7091

67066

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

338

1732

2.00

30.18

2.0

1.9

12.86

11.79

mg/l

1.44

322

1615

(3024731) MCV [Entitic mean volume] in Red Blood Cells

7172

68715

1.82

30.02

46.9

23.2

91.53

91.46

0.62

7140

67857

(3000963) Hemoglobin [Mass/volume] in Blood

7173

68731

1.83

29.97

47.5

23.4

129.80

135.84

g/l

176.19

7141

67889

(3026361) Erythrocytes [#/volume] in Blood

7172

68720

1.82

29.94

47.0

23.2

4.35

4.49

e12/l

92.22

7073

66831

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

7172

68721

1.82

29.93

48.9

23.7

39.12

40.75

27.75

7138

67834

(3010813) Leukocytes [#/volume] in Blood

7172

68730

1.82

29.79

47.1

23.2

7.10

6.73

e9/l

31.76

7072

66828

(3003181) Sodium [Moles/volume] in Urine

258

1201

2.19

29.73

2.1

1.3

55.31

63.01

mmol/l

2.04

195

983

(3035941) MCH [Entitic mass]

7170

68716

1.81

29.61

46.9

23.1

30.26

30.44

13.46

7139

67859

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

142

4.75

29.59

2.9

1.8

9.16

9.59

mg/l

0.28

121

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6612

62177

1.50

29.20

6.1

5.3

6.10

6.02

mmol/l

6.15

6211

56983

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

335

1733

1.98

29.11

1.7

1.6

—

(3004809) Band form neutrophils/Leukocytes in Blood

239

1088

2.24

29.10

3.1

3.6

1.51

1.43

0.13

220

961

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

535

3218

1.71

28.54

1.6

1.4

—

(3019225) pH of Specimen

905

6185

1.53

28.52

5.5

4.1

7.38

7.36

3.73

739

4426

(3012501) Base excess in Blood by calculation

273

1328

2.10

28.11

5.8

3.7

2.84

2.60

mmol/l

0.74

198

900

(3013290) Carbon dioxide [Partial pressure] in Blood

273

1329

2.09

28.06

5.8

3.7

5.02

5.00

kpa

0.19

265

1300

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

228

1036

2.24

27.90

1.1

—

(1616796) Gas panel - Central venous blood

297

1498

2.02

27.73

4.8

3.7

—

(3027315) Oxygen [Partial pressure] in Blood

273

1337

2.08

27.62

5.8

3.8

8.88

8.58

kpa

1.36

265

1307

(3021788) Differential panel - Synovial fluid

254

1219

2.12

27.11

1.7

1.5

—

1.00

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

108

345

3.16

26.78

1.3

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

176

728

2.45

26.72

3.2

3.5

6.14

21.50

nmol/l

0.82

170

711

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

106

338

3.17

26.37

1.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

591

3728

1.63

26.25

3.6

4.41

4.48

pmol/l

0.74

523

3331

(3025159) Blasts/Leukocytes in Blood

853

5860

1.51

26.10

4.8

4.5

0.12

0.41

1.45

308

1474

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

110

5.03

26.02

1.4

1.17

mmol/l

0.12

110

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

200

886

2.29

26.02

1.3

1.2

7.12

2.86

u/ml

0.74

299

(3010421) pH of Blood

376

2105

1.83

25.67

5.4

3.4

7.41

0.19

369

2079

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

112

377

3.00

25.42

1.2

1.1

—

0.62

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

295

1535

1.96

25.22

1.6

1.5

—

(3037121) Protein [Mass/volume] in Urine

375

2109

1.82

25.22

4.1

3.2

326.07

418.43

mg/l

0.85

242

965

(3013512) EKG study

2836

23884

1.30

25.02

4.2

3.5

0.38

0.78

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

5.48

25.01

10.8

11.1

4.26

5.22

mmol/l

3.19

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

288

3.29

24.99

1.4

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

288

3.29

24.99

1.4

1.7

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

155

624

2.51

24.96

1.1

96.37

97.95

0.30

144

583

(3024891) Influenza virus A+B Ag [Presence] in Specimen

274

1396

2.00

24.89

1.2

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

115

4.81

24.73

3.9

3.5

7.32

7.95

mg/l

0.31

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

191

850

2.28

24.60

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

123

447

2.78

24.30

1.1

1.0

294.85

289.91

mg/l

0.32

115

405

(3023420) DNA double strand Ab [Units/volume] in Serum

422

2493

1.73

23.99

1.8

1.7

7.82

6.24

iu/ml

0.41

566

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

184

815

2.29

23.98

1.1

118.26

115.47

0.49

171

727

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

237

3.49

23.90

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

237

3.49

23.90

1.3

1.4

—

(3000012) Reticulocyte production index

216

1026

2.14

23.71

2.0

2.2

0.93

0.92

0.07

158

671

(3006922) Hepatitis E virus Ab [Presence] in Serum

120

438

2.77

23.53

1.2

1.1

—

(4195642) Thrombophilia screening test

180

799

2.28

23.35

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

190

865

2.23

23.20

1.7

1.5

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

126

4.47

23.06

2.7

3.1

2030.96

3226.22

u/l

0.33

115

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

191

875

2.21

22.97

1.3

1.2

4.10

4.12

u/ml

0.01

100

383

(3027273) Bicarbonate [Moles/volume] in Venous blood

490

3051

1.65

22.86

5.8

3.4

24.53

25.23

mmol/l

3.86

468

2956

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

468

2903

1.65

22.16

4.3

3.7

54.35

67.43

u/ml

0.47

451

2804

(40761536) Microorganisms panel - Urine sediment

739

5094

1.50

22.09

5.7

3.7

—

(3022621) pH of Urine by Test strip

711

4871

1.51

21.89

2.9

2.5

6.00

6.04

0.55

468

3379

(1002224) Polysomnography panel

440

2695

1.67

21.88

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

185

869

2.16

20.94

1.4

1.3

0.11

0.23

nmol/l

2.42

(3001186) Copper [Moles/volume] in Serum or Plasma

141

4.07

20.80

1.5

1.1

16.68

16.26

umol/l

0.23

123

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

164

738

2.25

20.64

1.4

1.3

0.19

0.21

nmol/l

0.46

131

586

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

181

850

2.16

20.51

1.4

1.3

0.66

5.74

nmol/l

1.17

174

823

(3014148) Varicella zoster virus Ab [Titer] in Serum

151

658

2.32

20.50

1.2

1.1

—

(3024932) HLA-DR beta [Type]

188

3.59

20.47

1.0

1.1

—

(3024471) HLA-A [Type]

193

3.55

20.43

1.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

275

1501

1.86

20.39

1.6

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

225

1150

1.99

20.31

1.6

1.7

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

641

4376

1.51

20.02

11.8

6.8

24.35

24.66

mmol/l

1.10

620

4181

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3261

28465

1.26

20.00

2.2

1.9

1.42

1.35

mmol/l

5.54

2808

23609

(3017732) Neutrophils [#/volume] in Blood

1069

8030

1.39

19.94

3.8

3.2

4.68

4.52

e9/l

0.52

899

6919

(3017354) Segmented neutrophils/Leukocytes in Blood

159

718

2.24

19.86

2.9

3.6

61.20

57.29

1.41

147

616

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

491

3166

1.59

19.84

9.9

4.8

1.72

1.62

1.01

473

2989

(44790048) Parainfluenza type 2 nucleic acid detection

178

842

2.14

19.81

1.7

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

178

842

2.14

19.81

1.7

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

178

842

2.14

19.81

1.7

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

178

842

2.14

19.81

1.7

1.4

—

(40768443) Skin Pathology biopsy report

462

2939

1.61

19.75

1.3

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

241

1274

1.92

19.72

1.6

1.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

102

376

2.74

19.69

1.9

1.5

4.58

6.16

u/l

0.72

300

(40767503) Oxygen content in Capillary blood by calculation

262

1427

1.87

19.57

3.6

2.6

15.32

16.49

7.05

256

1400

(40768441) Liver Pathology biopsy report

119

476

2.52

19.52

1.8

1.3

—

(4062490) Immunoglobulin typing, IgG

138

592

2.36

19.44

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1724

13972

1.30

19.20

2.0

1.7

33012831.37

29346000.53

pmol/l

0.09

1454

11552

(3007930) Methemoglobin/Hemoglobin.total in Blood

453

2888

1.60

19.19

10.6

5.1

0.87

0.01

434

2722

(3028192) IgG subclass 2 [Mass/volume] in Serum

139

603

2.33

19.09

1.4

2.89

2.99

g/l

0.17

424

(3024139) IgG subclass 3 [Mass/volume] in Serum

139

603

2.33

19.09

1.4

0.51

0.43

g/l

0.26

422

(3039000) Anion gap in Blood by calculation

263

1447

1.85

19.03

13.8

6.6

11.29

mmol/l

0.00

245

1292

(3027135) IgG subclass 1 [Mass/volume] in Serum

139

604

2.33

19.02

1.4

6.81

6.83

g/l

0.01

424

(3018572) Chloride [Moles/volume] in Blood

263

1448

1.85

18.99

13.8

6.6

105.20

105.18

mmol/l

0.01

245

1293

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

704

4950

1.47

18.96

1.6

1.5

—

(40768446) Kidney Pathology biopsy report

233

3.20

18.91

2.1

1.6

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

115

467

2.48

18.30

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2121

17748

1.27

18.19

4.4

3.2

0.09

0.20

estimate

0.63

735

5513

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

611

4216

1.49

18.08

2.5

2.4

29.64

22.60

au/ml

0.78

395

(3029634) Reagin Ab [Titer] in Serum by VDRL

159

748

2.15

17.98

2.8

2.1

16.83

2.29

titre

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

261

1462

1.81

17.84

1.3

1.2

3.06

4.23

u/ml

0.18

103

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6339

60163

1.33

17.82

5.0

4.4

1.40

1.29

mmol/l

19.66

5938

55071

(3000475) Leukocytes [#/volume] in Synovial fluid

287

1657

1.76

17.72

1.6

16909.22

12254.74

e6/l

0.94

192

1154

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

309

1823

1.72

17.68

1.5

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

296

1730

1.74

17.51

1.3

2.58

2.95

u/ml

0.29

165

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

228

1232

1.88

17.49

1.1

3.61

10.31

eliau/ml

1.62

150

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

131

576

2.30

17.48

1.7

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

110

448

2.48

17.42

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

372

2.63

17.39

2.3

2.8

218.85

251.54

e6/l

0.81

323

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6720

64393

1.39

17.38

6.8

6.0

2.52

2.68

mmol/l

36.79

6364

59725

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

141

641

2.22

17.38

1.3

1.2

55.50

36.02

u/ml

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

311

1847

1.71

17.37

1.3

1.2

20.58

38.67

u/ml

0.75

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

115

480

2.42

17.27

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

108

439

2.48

17.18

1.1

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

106

428

2.50

17.10

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

105

423

2.50

17.02

2.2

2.0

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

111

460

2.43

16.94

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

111

460

2.43

16.94

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

391

2481

1.61

16.90

2.8

2.6

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

124

541

2.31

16.86

1.1

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

561

3862

1.49

16.77

1.3

53.92

51.34

au/ml

0.10

273

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

316

2.74

16.77

1.2

2.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

316

2.74

16.77

1.2

2.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

316

2.74

16.77

1.2

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

316

2.74

16.77

1.2

2.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

293

1730

1.72

16.73

1.3

4.31

6.13

u/ml

0.54

253

(3011412) CD3 cells [#/volume] in Blood

126

557

2.28

16.63

2.3

2.4

1141.88

1164.82

e6/l

0.11

105

500

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

362

2.59

16.21

2.4

2.7

513.43

516.52

e6/l

0.02

301

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

240

2.98

16.15

3.0

1.9

148.52

157.79

0.38

228

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6617

63390

1.35

15.95

5.9

5.3

4.42

4.60

mmol/l

34.19

6294

59032

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

176

3.31

15.80

1.2

1.3

—

(3045142) Bone marrow Pathology biopsy report

159

787

2.04

15.78

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

163

819

2.01

15.53

1.5

1.4

29577.54

45379.48

e6/l

0.77

460

(4024509) Urine culture

438

2910

1.54

15.51

2.0

1.8

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

174

3.29

15.39

1.2

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6575

62995

1.33

15.29

5.8

5.2

1.40

1.46

mmol/l

21.89

6225

58281

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

409

2.44

15.26

1.5

1.3

3.09

1.92

u/ml

0.33

238

(4268621) Lupus anticoagulant assay

131

611

2.16

15.21

2.5

2.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

120

541

2.24

15.15

1.2

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

120

541

2.24

15.15

1.3

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

120

541

2.24

15.15

1.2

1.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

161

3.37

15.14

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

577

8010

0.70

15.09

10.9

6.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

111

485

2.31

15.09

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

276

1650

1.70

15.09

3.0

2.3

121.84

129.60

g/l

4.97

222

1279

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

171

884

1.96

15.04

1.2

5.50

7.23

u/ml

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

210

1161

1.83

15.04

1.5

1.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

218

1227

1.80

14.73

1.2

172.00

318.76

titre

1.32

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

218

1227

1.80

14.73

1.2

—

248.33

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

125

582

2.17

14.60

2.4

20.73

31.14

iu/ml

0.83

(3023419) Bacteria identified in Sputum by Culture

175

922

1.92

14.57

2.8

2.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

260

2.79

14.57

4.5

5.2

59.24

1837.78

mg/l

0.83

181

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

356

2297

1.58

14.36

6.1

3.7

25.05

24.91

mmol/l

0.39

338

2101

(3023199) Leukocytes [#/volume] in Pleural fluid

175

931

1.90

14.16

1.5

1863.62

3109.23

e6/l

0.64

114

652

(3003434) Protein [Mass/volume] in Pleural fluid

195

1074

1.84

14.16

1.5

1.4

30.42

32.47

g/l

1.22

172

975

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

112

507

2.23

14.04

1.4

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

306

2.60

13.97

1.3

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

202

1131

1.81

13.91

1.8

1.9

4.88

5.01

mmol/24h

0.21

179

993

(3000093) Morphology [Interpretation] in Blood Narrative

129

627

2.08

13.51

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

235

1389

1.71

13.43

1.8

1.7

299.65

302.78

mu/l

0.05

217

1273

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

159

838

1.92

13.26

1.6

1.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2894

25677

1.21

13.25

5.9

5.5

2.60

3.17

ug/l

1.23

2652

23273

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

219

1275

1.74

13.22

1.6

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

162

862

1.90

13.13

2.3

2.0

1557.17

5216.25

u/l

2.04

334

(21494890) Protein electrophoresis panel - 24 hour Urine

141

717

1.98

13.06

2.1

2.2

—

(3016038) Potassium [Moles/volume] in Urine

433

2.28

13.04

2.2

1.1

36.22

35.31

mmol/l

0.13

378

(3009214) Lutropin [Units/volume] in Serum or Plasma

226

1336

1.71

12.93

1.4

10.33

10.98

u/l

0.27

168

1064

(3020876) Protein [Mass/time] in 24 hour Urine

164

881

1.88

12.92

2.1

2.5

1.39

1.32

g/24h

0.12

123

520

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

11.53

12.77

1.0

1.1

29.18

35.67

u/ml

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

11.53

12.77

1.0

1.1

25.24

27.20

u/ml

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

153

809

1.91

12.66

1.3

1.2

—

(3004451) EKG impression Narrative

384

2.33

12.53

1.3

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

130

656

2.00

12.33

3.7

3.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2361

20676

1.21

12.13

4.5

21.58

22.16

1.00

1136

10628

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

416

2.25

12.06

1.8

1.9

—

(3041672) Baker's yeast Ab [Presence] in Serum

11.03

12.00

1.0

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

10.03

11.96

1.6

1.7

223.00

170.17

ug/g

0.41

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

184

1051

1.77

11.91

1.6

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

139

727

1.93

11.91

1.4

1.3

—

nmol/l

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1801

15386

1.22

11.86

3.4

3.3

0.78

0.79

ug/l

0.17

1288

10318

(3000060) B lymphocytes [#/volume] in Blood

136

3.25

11.73

2.4

2.1

4.03

0.86

e9/l

0.37

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

233

2.67

11.70

1.6

1.7

13835.77

70342.11

u/ml

0.58

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

4.74

11.63

2.2

1.9

50.83

66.39

0.85

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

122

621

1.98

11.33

1.1

2.71

3.55

eliau/ml

0.52

296

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

196

1158

1.71

11.29

1.4

194.50

185.22

pmol/l

0.07

188

1132

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

279

2.49

11.25

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

218

1331

1.66

11.10

3.2

1.6

0.97

0.83

nmol/l

1.87

197

1144

(4094501) Cardiovascular stress test using bicycle ergometer

284

1849

1.56

11.09

1.1

—

(4281824) Cell count and differential, peritoneal fluid

131

689

1.92

11.07

1.2

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

471

2.12

11.05

1.2

1.3

10.12

9.15

mmol/l

1.26

433

(21494434) Karyotype in Bone marrow

115

579

2.00

11.03

1.1

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

337

2288

1.49

10.83

1.2

1.3

0.46

1.15

u/ml

1.52

178

(3033799) Differential panel - Peritoneal fluid

231

2.61

10.83

1.8

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

219

1349

1.64

10.79

1.2

46.73

45.94

u/ml

0.02

133

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

5.13

10.77

2.1

1.8

22.22

14.86

—

(3004616) Nuclear Ab [Presence] in Serum

142

777

1.84

10.64

1.5

1.2

—

(3044927) Protein electrophoresis panel - Urine

122

637

1.93

10.56

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

262

1695

1.57

10.53

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

228

1434

1.61

10.34

3.1

0.78

0.82

nmol/l

0.53

176

1185

(40768806) Pleura Pathology biopsy report

147

824

1.80

10.20

1.5

1.6

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

277

2.39

9.98

1.2

1.1

4.40

3.08

iu/ml

—

(3011985) Renin [Units/volume] in Plasma

162

946

1.73

9.79

1.4

72.91

64.09

mu/l

0.18

149

856

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

106

542

1.97

9.78

1.3

1.2

76.20

60.65

u/ml

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

116

3.20

9.69

1.0

1.3

413.71

334.24

pmol/l

0.31

(3027923) C peptide [Moles/volume] in Serum or Plasma

377

2.16

9.62

1.4

1.20

1.26

nmol/l

0.18

292

(3002619) Bacteria identified in Specimen by Culture

171

2.76

9.51

1.2

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

254

1672

1.54

9.49

2.0

1.9

4.27

7.52

iu/l

0.44

660

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

498

3727

1.36

9.33

1.2

171.26

137.23

u/ml

0.82

148

1391

(3023323) Follitropin [Units/volume] in Serum or Plasma

289

1964

1.49

9.29

1.5

1.4

28.34

32.81

iu/l

1.67

235

1675

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

6.89

9.29

1.2

1.45

1.81

iu/ml

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

116

623

1.88

9.28

1.4

1.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

208

2.56

9.26

5.5

2.4

10.72

10.30

kpa

0.45

208

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

208

2.56

9.26

5.5

2.4

4.95

4.92

kpa

0.07

208

(3045414) Leukocytes [Presence] in Urine

784

6265

1.28

9.19

2.4

2.0

0.01

estimate

0.31

138

1277

(3008757) Leukocyte morphology finding [Identifier] in Blood

120

655

1.85

9.13

3.2

4.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

237

1552

1.54

9.08

1.4

1.3

—

(3047189) Immunofixation for 24 hour Urine

341

2.18

9.04

1.9

1.8

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

176

2.68

9.02

1.4

1.3

108.52

112.05

0.39

157

(3026692) Albumin [Mass/volume] in Peritoneal fluid

182

2.65

8.99

1.4

1.3

10.20

13.07

g/l

1.70

142

(3034274) Bile acid [Moles/volume] in Serum --fasting

310

2.24

8.97

2.2

2.0

23.57

14.02

umol/l

0.63

220

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

120

662

1.83

8.84

1.5

1.8

—

(3011288) Drugs identified in Urine by Screen method Nominal

146

855

1.72

8.78

2.6

2.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

701

5556

1.29

8.76

6.2

3.8

1.22

1.23

mmol/l

2.16

612

4723

(3023511) Choriogonadotropin [Units/volume] in Urine

379

2.10

8.73

1.4

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

264

2.32

8.66

1.7

1.8

169.03

110.95

umol/l

0.39

132

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

109

588

1.87

8.63

3.0

2.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

401

2.06

8.62

1.3

1.4

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

4.38

8.60

1.3

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

336

2.15

8.54

3.1

2.9

36.40

36.65

0.03

177

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

330

2.16

8.51

2.2

2.1

92.43

190.33

ug/min

0.59

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

120

673

1.80

8.40

1.2

—

(3000330) Specific gravity of Urine by Test strip

440

3285

1.36

8.39

3.5

3.1

1.02

ratio

0.11

374

2989

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

113

626

1.82

8.24

1.2

—

39.22

—

(3008295) Osmolality of Serum or Plasma

124

708

1.76

8.18

1.4

276.80

278.96

mosm/kgh2o

0.40

546

(3011335) Digoxin [Mass/volume] in Serum or Plasma

4.21

8.18

2.6

2.5

0.55

0.59

ug/l

0.21

(3045788) Cell count panel - Pleural fluid

131

761

1.73

8.14

1.5

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

7.52

8.14

1.5

1.4

1.21

2.58

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

7.52

8.14

1.5

1.4

0.54

1.18

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

7.52

8.14

1.5

1.4

1.07

3.64

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

7.52

8.14

1.5

1.4

2.52

3.52

mg/l

0.24

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

7.52

8.14

1.5

1.4

0.69

3.75

mg/l

1.33

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

7.52

8.14

1.5

1.4

1.42

3.83

mg/l

0.94

(3001964) Herpes simplex virus Ag [Presence] in Specimen

152

2.71

8.06

1.7

1.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

104

3.09

7.95

1.2

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

519

1.88

7.91

1.4

13.21

12.59

u/l

0.46

498

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

484

1.91

7.90

1.5

1.6

24.63

25.47

u/ml

0.07

101

(3028707) Methadone [Presence] in Urine by Screen method

101

549

1.85

7.85

2.8

2.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

733

5921

1.26

7.85

2.5

2.2

13.12

13.41

nmol/l

0.31

649

5354

(3040151) Glucose [Moles/volume] in Capillary blood

134

792

1.70

7.84

4.0

6.4

6.99

7.57

mmol/l

1.57

123

674

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

382

2.03

7.82

2.8

2.7

0.69

0.63

e9/l

0.54

366

(43055442) Apixaban [Mass/volume] in Serum or Plasma

112

2.95

7.63

1.6

84.47

112.69

ug/l

1.14

101

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

507

1.86

7.50

1.6

1.2

99.24

109.80

pmol/l

1.09

507

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

130

2.78

7.46

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

153

2.62

7.43

1.2

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

134

806

1.67

7.37

1.1

3.84

3.21

u/ml

0.26

401

(3045683) HLA typing for celiac disease panel - Blood or Tissue

258

2.22

7.35

1.0

—

(4198724) Urine methamphetamine measurement

154

2.61

7.34

1.5

1.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

249

1727

1.46

7.31

2.3

1.9

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

100

3.01

7.17

1.8

1.5

1550.00

5108.89

u/ml

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

180

2.45

7.14

1.3

1.5

81.75

237.01

nmol/24h

1.29

180

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

383

1.97

7.07

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

187

1235

1.53

6.99

1.2

1.3

30.00

33.82

u/l

0.24

170

1060

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

541

1.80

6.99

2.0

1.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

139

858

1.63

6.95

1.1

15.59

13.46

au/ml

0.12

190

(3042631) Mycobacterium sp identified in Specimen

152

960

1.60

6.92

2.8

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

521

1.81

6.92

1.6

1.5

—

(3036782) Glucose [Moles/volume] in Pleural fluid

122

729

1.68

6.91

1.3

1.4

6.55

6.34

mmol/l

0.31

114

673

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

3.56

6.85

1.2

122.50

120.85

ug/l

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

146

916

1.61

6.84

1.2

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

117

694

1.70

6.82

2.4

2.0

19.74

27.25

mg/l

1.17

278

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

136

840

1.63

6.79

1.1

1.0

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

208

1415

1.48

6.76

1.4

29.75

28.59

e6/l

0.02

146

1039

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.02

6.75

1.1

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

109

636

1.72

6.75

1.7

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

229

2.24

6.74

1.6

1.7

12892.55

15943.92

e6/l

0.10

112

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

115

2.79

6.72

1.3

115.63

108.89

0.38

110

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.21

6.68

2.0

1.6

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

682

5569

1.25

6.65

3.5

2.7

63.15

64.37

ml/min/173m2

0.36

337

2244

(3017704) Immunofixation for Urine

371

1.95

6.64

1.3

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

420

3229

1.32

6.63

2.1

1.8

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

142

893

1.60

6.60

1.2

1.3

274.69

317.18

pmol/l

0.98

120

756

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

151

2.52

6.58

1.3

1.1

94.82

86.57

0.59

(3023410) Appearance of Cerebral spinal fluid

103

596

1.74

6.58

1.5

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

3.81

6.52

2.1

1.8

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

147

2.52

6.41

1.3

95.00

86.78

0.40

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

117

710

1.66

6.29

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

269

2.09

6.28

1.6

1.8

1819.22

3804.86

e6/l

0.28

175

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

142

905

1.58

6.26

1.7

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

283

2.06

6.25

2.3

2.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

208

1441

1.46

6.20

1.5

1.4

677.24

1430.50

e6/l

0.98

154

1137

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

525

1.76

6.19

1.3

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

125

779

1.61

6.07

1.1

0.82

0.94

u/ml

0.11

338

(3002331) Protein [Mass/volume] in Peritoneal fluid

158

2.41

6.01

1.2

1.3

24.10

25.44

g/l

0.21

121

(3006571) Granulocytes/Leukocytes in Synovial fluid

124

775

1.61

5.96

1.8

1.5

61.65

59.55

0.22

471

(3034426) Prothrombin time (PT)

171

2.35

5.96

1.2

29.40

28.94

0.12

171

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

112

2.69

5.90

1.6

1.2

89.30

79.41

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.90

5.87

1.6

—

(3017569) Oxygen content in Arterial blood

402

1.85

5.87

3.1

2.2

15.75

16.08

0.37

402

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

360

1.90

5.84

1.6

1.4

—

(3018405) Lactate [Moles/volume] in Arterial blood

298

2223

1.35

5.81

5.8

4.1

1.50

1.40

mmol/l

0.75

290

2184

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

271

2.04

5.80

1.6

1.7

2.79

6.39

nmol/l

1.16

223

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

566

1.70

5.79

1.2

1.3

12.42

11.73

u/l

0.23

521

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

163

1092

1.50

5.78

1.2

0.52

0.97

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

155

2.39

5.77

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.61

5.75

2.3

1.6

64.78

47.00

umol/l

0.87

(3020191) Ethanol [Moles/volume] in Serum or Plasma

545

1.72

5.73

1.6

1.3

0.97

1.20

promille

0.91

431

(3009871) Measles virus Ab [Titer] in Serum

219

2.15

5.73

1.6

3760.00

3357.65

titre

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

3.91

5.70

1.7

1.4

33.20

12.85

pmol/l

0.71

(3047007) Chlamydophila sp Ab [Presence] in Serum

118

737

1.61

5.70

1.3

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

200

1400

1.44

5.68

1.2

1.1

2.74

4.02

1.27

162

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

145

952

1.53

5.65

1.2

1.1

1.85

1.68

u/ml

0.06

508

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

451

1.78

5.65

1.3

360.00

663.68

titre

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

316

1.94

5.60

1.2

1.1

31.11

17.55

u/ml

0.69

132

(3016879) Cocaine [Presence] in Urine

179

1231

1.47

5.59

2.4

1.8

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

153

1020

1.51

5.56

2.3

1.7

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

226

1624

1.40

5.56

1.4

1.3

642.43

563.09

mg/l

0.29

218

1550

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

227

1635

1.40

5.51

2.6

2.3

164.35

112.26

ug/min

0.68

134

979

(37208534) Antinuclear antibody arbitrary concentration in serum

197

2.19

5.48

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

106

652

1.63

5.47

2.2

1.8

10352.00

1360.00

titre

—

(3043410) Blood group antigens tested for on Red Blood Cells

153

2.36

5.46

2.7

1.6

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

428

3393

1.28

5.41

6.4

3.8

47.20

47.26

0.01

421

3342

(3042517) Benzodiazepines panel - Urine

5.61

5.36

2.2

2.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

357

1.86

5.34

4.0

3.9

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

444

3544

1.27

5.31

2.2

1.8

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.71

5.29

1.3

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

506

1.71

5.26

3.2

2.6

23.02

30.70

mg/l

1.27

357

(3006462) Nitrate [Presence] in Urine

256

2.00

5.15

3.9

3.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

334

1.86

5.10

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

321

1.88

5.05

1.1

1.06

ratio

0.19

258

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

357

1.83

5.04

1.1

22.79

26.49

u/l

0.35

316

(37021550) Renin [Units/volume] in Plasma --upright

110

2.55

5.03

1.0

1.3

410.45

70.54

mu/l

0.71

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

358

1.82

5.00

1.1

78.04

86.75

u/l

0.55

315

(3010726) Horse dander IgE Ab [Units/volume] in Serum

115

739

1.56

4.99

1.1

1.24

1.33

u/ml

0.05

376

(3008898) HLA-B27 [Presence]

237

1756

1.36

4.89

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

393

3125

1.27

4.87

1.8

1.6

—

(4211845) Urine protein measurement

291

1.90

4.80

3.7

3.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

131

2.37

4.80

1.1

1333.33

962.07

titre

—

(3020393) Adenovirus Ag [Presence] in Stool

3.07

4.78

1.4

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

186

1332

1.41

4.73

2.3

1.7

—

(3020891) Body temperature

403

3228

1.26

4.72

7.1

4.4

36.95

36.90

°c

1.41

396

3198

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1475

0.63

4.71

1.3

1.5

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

102

2.55

4.70

1.1

1.2

0.48

0.67

umol/24h

—

(3026389) Candida sp identified in Specimen by Organism specific culture

122

806

1.52

4.70

1.3

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

114

2.46

4.69

1.3

1.2

83.71

72.21

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

108

2.51

4.69

1.3

16.07

12.89

0.22

(3028300) Cannabinoids [Presence] in Urine

187

1343

1.40

4.68

2.4

1.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

231

2.00

4.68

1.2

2.4

—

(3027008) Opiates [Presence] in Urine

186

1335

1.40

4.67

2.3

1.7

—

(3027944) Amphetamines [Presence] in Urine

184

1319

1.40

4.66

2.4

1.7

—

(3028433) Virus identified in Specimen by Culture

192

2.09

4.59

1.3

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

4.52

4.54

1.4

1.3

293.86

321.13

umol/24h

0.21

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

101

646

1.57

4.51

1.3

1.5

—

(3036525) Urea [Moles/time] in 24 hour Urine

4.17

4.50

2.0

2.9

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3.15

4.48

1.2

1.1

12.40

13.71

nmol/l

—

(3032057) Clostridioides difficile [Presence] in Stool

100

2.50

4.36

2.1

2.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.10

4.35

1.3

1.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

232

1.95

4.28

1.1

2.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

232

1.95

4.28

1.1

2.4

—

(3045424) Erythrocytes [Presence] in Urine

394

3188

1.25

4.26

2.6

2.1

0.01

0.02

estimate

0.25

106

1016

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

111

736

1.52

4.24

1.2

1.1

1.68

3.38

1.08

109

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2729

25545

1.11

4.24

4.9

3.6

0.03

0.36

estimate

1.47

754

5742

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.56

4.20

3.7

2.8

50.22

32.79

mg/l

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

140

2.22

4.17

3.1

2.3

3367.00

60.12

ug/l

0.48

140

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

6.93

4.16

6.4

6.8

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

181

2.05

4.08

1.6

1.9

75.46

29.32

u/l

0.43

165

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.62

4.05

3.8

2.3

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

355

1.72

3.98

1.8

1.5

5.56

6.55

u/l

0.89

309

(3008536) Aspergillus sp Ab [Presence] in Serum

143

2.17

3.97

1.7

2.3

—

(40768795) Lymph node Pathology biopsy report

107

715

1.50

3.97

1.5

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

118

2.29

3.93

1.1

—

17.33

u/ml

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

262

1.84

3.88

1.1

83.33

574.52

ng/l

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

107

719

1.50

3.87

1.4

1.3

1.43

1.46

nmol/l

0.10

642

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

7.28

3.85

1.3

24.23

38.17

umol/24h

—

(3002079) Sodium [Moles/time] in 24 hour Urine

270

1.82

3.85

1.3

170.13

168.09

mmol/24h

0.06

270

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

4.29

3.81

5.8

4.6

—

(3020650) Glucose [Presence] in Urine

214

1.92

3.80

1.9

1.6

0.00

0.06

estimate

1.34

214

(1761868) Lipid panel - Serum or Plasma

2268

24286

0.91

3.78

3.4

3.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

193

1448

1.34

3.76

1.4

1.3

3.77

3.86

mmol/l

0.51

178

1378

(4212803) Bone marrow aspirate examination

2.91

3.73

1.1

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

326

1.72

3.68

1.1

1.6

—

(3028717) Thiamine [Mass/volume] in Blood

2.42

3.63

1.2

62.14

64.02

ug/l

0.16

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

396

1.65

3.61

1.7

1.5

—

(21494755) Public health laboratory ask at order entry panel

411

4934

0.82

3.60

1.4

—

(21494814) CD8 cells/Lymphocytes in Specimen

255

1.81

3.57

1.7

1.9

30.37

31.41

0.16

255

(3002523) Influenza virus A Ag [Presence] in Specimen

122

861

1.42

3.47

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

122

861

1.42

3.47

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

287

1.75

3.47

1.4

1.9

2.02

4.79

ug/l

1.61

215

(3016750) Collection duration of Urine

373

1.64

3.37

2.3

2.1

502.38

495.02

min

0.33

266

(3045716) Anion gap in Serum or Plasma by calculation

113

792

1.43

3.35

5.8

3.1

11.84

10.60

mmol/l

2.46

113

781

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.83

3.35

1.0

0.01

0.37

u/ml

—

(3025130) Human papilloma virus identified in Specimen

103

712

1.45

3.30

1.6

1.8

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

169

1.96

3.27

6.6

7.8

5.35

5.49

kpa

0.14

169

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

185

1413

1.32

3.24

2.5

1.8

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

177

1.92

3.22

1.3

149.76

117.41

nmol/l

0.42

130

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

3.53

3.19

3.7

11.7

107.75

105.35

g/l

0.25

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

228

1.80

3.18

1.2

1.3

896.87

279.47

ug/l

0.56

126

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

341

1.65

3.17

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.73

3.15

1.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

319

1.67

3.13

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

381

1.61

3.12

1.7

1.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

640

1.46

3.07

1.6

1.5

0.23

0.32

nmol/l

1.20

453

(3013336) Amino acids [Identifier] in Serum or Plasma

7.51

3.05

2.8

4.0

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

7.51

3.05

3.2

4.6

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.55

2.98

1.3

1.1

—

(3022229) Phosphate [Moles/volume] in Urine

3.85

2.97

2.1

1.8

12.67

16.56

mmol/l

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

226

1.77

2.97

1.3

1.4

2.29

2.25

0.01

201

(40768800) Prostate Pathology biopsy report

223

1770

1.27

2.95

1.2

—

(3035880) pH of Pleural fluid

403

1.57

2.94

1.2

1.3

7.40

0.03

278

(3010144) Erythrocytes [#/volume] in Synovial fluid

605

1.46

2.94

1.5

1.4

95036.90

113593.05

e6/l

0.13

404

(3014271) Vancomycin [Susceptibility]

287

1.68

2.93

3.0

2.8

—

(3044242) Glucose [Moles/volume] in Arterial blood

388

1.58

2.92

3.6

1.9

7.85

8.31

mmol/l

0.45

388

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

565

1.47

2.92

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

454

1.52

2.86

2.1

2.2

3.35

3.85

ug/l

0.27

423

(3052592) Norovirus Ag [Presence] in Stool

2.19

2.82

1.3

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.34

2.80

5.0

2.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

433

1.53

2.78

1.7

1.4

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.92

2.77

2.4

1.7

—

(4015189) Microbial culture of sputum

152

1.91

2.74

2.7

2.0

—

(3044007) Cell count panel - Peritoneal fluid

236

1.70

2.60

1.7

1.8

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.19

2.56

2.2

1.5

—

0.86

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

2.36

2.55

1.4

1.3

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

5.46

2.54

1.5

1.0

2.33

3.27

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

276

1.63

2.54

1.5

1.9

38.40

39.88

g/l

0.75

276

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.42

2.53

2.6

1.7

—

(3034891) Synovial lining cells/cells in Synovial fluid

323

1.58

2.53

1.7

1.4

3.36

3.46

0.02

(40768793) Breast Pathology biopsy report

186

1475

1.27

2.53

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

284

1.62

2.53

1.2

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

300

1.60

2.52

1.0

1.1

1126.88

1474.39

miu/ml

1.84

300

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

3.23

2.51

8.9

7.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

277

1.63

2.51

3.9

3.4

1.36

1.33

0.04

277

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

179

1.79

2.50

1.3

1.2

18.22

11.87

pmol/l

0.45

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.98

2.48

1.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

187

1.77

2.48

1.3

1.2

42.16

40.80

g/l

0.25

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

4.38

2.47

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

3.81

2.46

1.4

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

145

1.87

2.41

1.3

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

189

1.75

2.40

1.5

1.6

14.74

16.88

pmol/l

1.02

159

(3005532) Lymphocytes/Leukocytes in Pleural fluid

265

1.63

2.40

1.3

1.4

54.31

67.15

1.40

228

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

565

1.42

2.38

1.1

1.0

0.46

0.23

u/ml

0.25

194

(3009466) Valproate [Moles/volume] in Serum or Plasma

119

899

1.33

2.35

5.5

5.1

357.85

363.63

umol/l

0.19

107

762

(4034850) Laboratory test

164

2064

0.79

2.35

11.1

10.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

111

1.98

2.35

1.6

1.7

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

243

2005

1.22

2.34

2.0

1.8

42.50

43.17

nmol/l

0.18

236

1944

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

170

1.77

2.27

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

2.22

2.27

1.3

1.1

92.20

76.77

ug/l

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.75

2.27

1.3

1.1

7.36

18.25

u/l

0.91

(40762887) Creatinine [Moles/volume] in Blood

2.86

2.20

1.4

—

(44813793) Dust mix specific IgE antibody measurement

360

1.50

2.18

1.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

136

1.84

2.17

3.2

5.9

53.08

57.06

u/l

0.08

131

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

3.69

2.15

5.3

6.2

557.86

362.42

umol/l

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

128

993

1.29

2.13

1.1

83.30

992.15

iu/ml

0.84

216

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

159

1.76

2.12

4.0

1.9

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

385

0.54

2.12

1.5

1.6

—

(3033099) Centromere Ab [Titer] in Serum

123

1.87

2.11

1.2

1.1

—

(3025577) Chromium [Mass/volume] in Blood

446

1.44

2.09

2.1

2.2

1.62

2.49

ug/l

2.49

371

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

193

1577

1.23

2.08

2.0

1.8

201.61

202.54

pmol/l

0.04

173

1488

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

166

1335

1.25

2.07

1.3

190.06

223.47

miu/ml

0.42

553

(3020491) Glucose [Moles/volume] in Blood

440

1.44

2.04

1.6

2.1

7.26

7.18

mmol/l

0.09

314

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

4.00

2.04

1.0

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.00

2.04

2.2

2.6

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.50

2.01

1.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.15

1.98

1.5

1.3

—

(3033086) Enterovirus Ab [Titer] in Serum

4.55

1.94

1.2

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

199

1649

1.21

1.90

4.4

2.9

1.71

1.66

mmol/l

0.22

194

1598

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.09

1.86

1.7

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

129

1.79

1.85

1.3

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

114

1449

0.78

1.85

4.8

3.2

27.49

28.94

mg/l

0.17

1003

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.39

1.85

2.7

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

358

1.46

1.84

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

143

1763

0.81

1.79

1.2

1.1

0.59

0.60

ratio

0.11

299

(3023430) Cat dander IgE Ab [Units/volume] in Serum

617

1.33

1.75

1.0

1.1

3.21

3.03

u/ml

0.04

272

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.90

1.75

1.6

1.8

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.90

1.75

1.3

182.54

172.61

ng/l

0.03

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

3.33

1.74

1.0

1.2

1.32

1.42

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

734

0.71

1.74

1.2

7.05

7.67

mmol/l

0.79

639

(3004775) Volume in Urine collected for unspecified duration

523

1.36

1.74

2.3

677.98

655.92

0.18

349

(3003329) Lymphocytes/Leukocytes in Synovial fluid

601

1.33

1.73

1.7

1.5

23.30

28.22

0.71

358

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

104

1.83

1.66

2.5

3.8

76.86

106.51

ng/l

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

237

2024

1.18

1.66

1.8

1.7

6.05

4.47

mg/l

0.75

188

1514

(3013762) Body weight Measured

3.57

1.61

1.4

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

2.69

1.58

1.4

1.2

1.57

0.94

u/field

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.69

1.58

1.6

1.0

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

329

1.43

1.57

1.2

0.53

0.58

ratio

0.47

196

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

191

1.57

1.56

1.1

1.7

9.77

9.14

ug/l

0.33

191

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

231

1.52

1.56

1.1

96.97

95.76

0.09

177

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.27

1.55

1.6

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.11

1.54

1.1

1.2

1.45

1.76

umol/24h

0.64

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

122

1.72

1.54

1.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

667

1.29

1.52

1.1

2.20

2.96

u/ml

0.32

341

(3037692) Legionella sp identified in Specimen by Organism specific culture

233

1.50

1.51

1.7

1.3

—

(40757373) Influenza virus identified in Isolate

116

1.73

1.48

2.2

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

281

0.57

1.47

1.3

1.5

75.26

57.50

ug/l

0.42

281

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.12

1.44

1.0

2.9

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.73

1.43

1.7

1.2

783.97

533.26

nmol/l

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

156

1.60

1.43

1.2

1.83

1.55

mmol/l

0.34

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

380

1.37

1.40

1.1

3.32

6.35

nmol/l

0.94

(3038515) Glucose [Moles/volume] in Venous blood

163

1375

1.19

1.37

4.3

3.0

7.70

7.78

mmol/l

0.16

158

1334

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.80

1.37

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

348

0.63

1.36

1.7

1.8

—

(3019150) Specific gravity of Urine by Refractometry

1418

14916

0.94

1.36

4.9

3.9

1.02

1.12

kg/l

0.50

994

9803

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.94

1.36

1.0

0.04

0.21

u/ml

—

(44806071) Cardiolipin IgM antibody measurement

1.83

1.35

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.83

1.35

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.75

1.34

1.6

1.8

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

105

1.72

1.32

1.2

31.33

359.92

u/l

0.59

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.35

1.29

1.5

1.1

—

(3022475) Manganese [Moles/volume] in Blood

2.35

1.29

1.4

1.3

0.16

umol/l

—

(3017509) Phencyclidine [Presence] in Urine

2.35

1.29

1.3

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

210

1.48

1.27

1.3

1.4

30.60

20.11

0.92

195

(3005011) Chlamydia sp Ab [Titer] in Serum

1.79

1.26

1.8

1.6

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.40

1.24

3.5

3.9

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

161

1882

0.85

1.23

1.2

1.49

1.52

g/l

0.82

161

1882

(3050129) First trimester maternal screen panel - Serum or Plasma

538

0.72

1.22

1.4

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.91

1.22

1.1

1.0

7.99

7.53

u/ml

0.04

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

155

1.55

1.22

2.2

1.9

3.88

419.07

pmol/l

—

(3019174) dRVVT (LA screen)

2.11

1.18

1.0

1.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

264

1.40

1.18

1.1

0.32

2.38

u/ml

1.19

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

384

1.33

1.17

1.1

8.41

10.93

iu/ml

0.31

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

165

1.52

1.17

1.2

1.3

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

199

0.55

1.17

1.3

60.55

58.73

0.08

165

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.93

1.16

1.3

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.77

1.16

1.8

1.7

0.45

1.31

mmol/l

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.00

1.16

1.0

1.9

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

182

1.49

1.15

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.05

1.15

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

2.05

1.15

1.0

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

176

1.48

1.09

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

168

1.49

1.09

1.0

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

806

0.79

1.08

1.5

1.6

1079.98

1039.84

mu/l

0.09

652

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.19

1.08

1.0

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

2.19

1.08

1.0

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.87

1.07

1.1

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.71

1.05

1.1

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

305

1.35

1.05

1.4

1.2

51.29

59.76

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

534

1.26

1.04

5.8

167.02

81.14

u/ml

0.38

172

(3015076) Soybean IgE Ab [Units/volume] in Serum

220

1.41

1.04

1.0

2.00

0.26

u/ml

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.63

1.03

1.3

1.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.06

1.02

1.0

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.92

1.02

7.1

6.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

559

6004

0.93

1.02

2.1

3.38

3.47

ratio

1.23

460

4795

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

205

1.42

1.00

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.84

0.98

1.3

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

132

1.52

0.96

8.8

6.9

10.14

10.67

0.51

132

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

165

1.46

0.96

1.1

—

(3024263) Appearance of Synovial fluid

337

1.31

0.95

1.7

1.6

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.77

0.94

3.6

3.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

435

1.27

0.93

1.0

1.1

281.68

299.45

mg/l

0.25

379

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

453

1.26

0.93

1.1

1.2

40.95

45.00

mg/l

0.36

381

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

394

4273

0.92

0.93

1.8

3.28

3.45

mmol/l

2.44

293

3056

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

176

1.42

0.90

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

376

1.28

0.89

1.1

—

(3011544) Albumin [Mass/volume] in Pleural fluid

1.69

0.88

1.1

1.2

14.25

17.50

g/l

0.75

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.91

0.88

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

111

1.53

0.87

2.6

3.3

—

(3050794) Legionella sp Ab [Presence] in Serum

1.76

0.83

1.0

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

1972

19143

1.04

0.82

5.3

3.9

0.00

estimate

2.97

819

6424

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

224

1.34

0.79

1.4

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.79

0.0

1.1

—

66.46

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.76

0.0

1.1

—

8.00

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.70

0.75

1.6

1.1

113.78

94.19

titre

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

814

7767

1.05

0.73

1.4

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

2.00

0.72

1.0

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

1.80

0.72

1.6

1.8

—

(40765096) Chromosome analysis panel by Banding

211

1.33

0.71

1.2

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.92

0.70

1.2

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.64

0.68

1.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.53

0.68

1.1

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.59

0.68

1.1

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

237

0.72

0.65

1.1

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

111

1.44

0.65

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.59

0.65

3.0

4.6

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.55

0.62

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.55

0.62

1.0

1.2

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

174

1.32

0.59

1.6

1.2

37.94

37.04

0.04

114

(3042010) Triglyceride [Moles/volume] in Pleural fluid

131

1.37

0.59

1.1

1.2

1.44

1.33

mmol/l

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.71

0.57

1.5

1.9

1.18

0.71

umol/l

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.51

0.56

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.45

0.55

1.2

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.45

0.55

1.2

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.45

0.55

1.2

1.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.46

0.54

1.0

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.50

0.54

1.1

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

207

1.26

0.49

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

399

1.18

0.49

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.47

0.47

1.4

1.5

0.55

0.51

e9/l

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

457

1.16

0.46

1.6

1.8

381.00

359.40

mu/l

0.10

368

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

245

1.23

0.46

1.2

1.1

—

(40762814) Titanium [Mass/volume] in Blood

120

1.33

0.46

2.4

2.5

2.31

4.25

ug/l

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.43

0.46

1.4

1.3

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

157

1.27

0.43

6.7

6.0

63.09

70.42

0.54

127

(3051101) Glucose [Moles/volume] in Cord blood

130

0.69

0.43

5.9

7.1

8.59

8.55

mmol/l

—

130

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

452

1.15

0.42

1.4

1.3

155.81

187.24

pmol/l

0.63

452

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.43

0.41

2.3

2.2

21.40

20.10

umol/l

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

167

1.26

0.41

1.1

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.40

0.0

1.2

—

17.16

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

520

1.14

0.40

2.0

1.9

1.45

1.55

u/field

0.08

277

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

123

1.30

0.40

1.0

1.3

1.02

88.33

mg/l

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.40

0.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.36

0.40

1.2

1.5

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

251

1.20

0.39

1.1

1.0

1.01

0.88

u/ml

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

166

1776

0.93

0.37

1.2

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

327

1.16

0.37

1.1

1.06

1.15

u/l

0.35

146

(1761482) Bacteria [#/volume] in Urine by Culture

166

1555

1.07

0.35

4.5

3.7

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

119

1.26

0.31

1.0

1.3

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

230

0.83

0.31

1.1

1.2

11.84

11.54

mm/h

0.05

230

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

164

0.79

0.30

1.1

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

523

1.11

0.30

1.1

1.0

289.69

331.29

ng/l

0.67

381

(3036048) Francisella tularensis Ab [Titer] in Serum

147

1.22

0.30

1.1

1.2

—

325.00

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

129

1.24

0.30

2.0

1.7

9.31

2.43

ug/l

1.54

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

524

1.11

0.30

1.1

1.0

744.77

702.87

ng/l

0.33

365

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

524

1.11

0.30

1.1

1.0

37.39

41.68

ng/l

0.52

375

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

325

1.14

0.29

1.4

1.8

2.68

2.83

u/field

0.04

227

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.23

0.29

1.7

1.8

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

677

0.92

0.26

3.0

4.3

76.80

72.75

u/ml

0.05

667

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

395

1.11

0.26

8.0

6.9

70.26

145.31

ug/l

0.35

259

(3001019) Free T4 and TSH panel - Serum or Plasma

260

2498

1.04

0.26

1.6

1.7

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

0.67

0.25

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.22

0.25

1.2

1.1

—

(3006270) Folate [Moles/volume] in Blood

483

1.10

0.24

1.1

346.12

368.18

nmol/l

0.34

403

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.25

0.22

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

181

1.16

0.22

1.2

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

144

1.18

0.22

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.19

0.21

1.0

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

792

8067

0.98

0.21

5.2

5.1

32.48

32.60

0.10

552

5254

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

102

0.78

0.21

1.6

1.5

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

189

1966

0.96

0.20

1.5

1.2

0.87

0.89

g/l

0.67

189

1961

(40758292) HTLV I+II Ab panel - Serum

123

0.81

0.20

1.3

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

240

1.13

0.20

3.2

2.9

30.71

28.51

umol/l

0.44

177

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

308

0.91

0.16

1.1

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.21

0.15

1.9

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

693

6829

1.02

0.15

1.6

1.5

—

6.50

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

615

1.06

0.14

1.3

25.29

31.87

u/l

0.81

506

(4146454) Self-monitoring of blood glucose

745

0.95

0.13

3.0

2.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

104

1.15

0.12

1.1

16.11

37.94

iu/ml

1.38

104

(3000034) Microalbumin [Mass/volume] in Urine

600

1.05

0.12

3.8

3.0

30.35

61.10

mg/l

1.06

444

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

282

0.92

0.12

1.3

5.83

6.07

mmol/l

0.54

265

(3022689) Creatine [Moles/volume] in Urine

230

0.91

0.11

1.8

1.4

7.72

8.01

mmol/l

0.11

230

(3047352) Trisomy 18 risk [Likelihood] in Fetus

373

0.94

0.11

1.5

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

475

0.95

0.10

1.5

58.79

62.09

ug/l

0.15

387

(3043238) Trisomy 21 risk [Likelihood] in Fetus

382

0.94

0.10

1.6

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

443

0.95

0.10

1.5

0.92

0.94

ratio

0.10

277

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

443

0.95

0.10

1.5

1.4

0.99

1.17

ratio

0.64

277

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

443

0.95

0.10

1.5

1.40

1.20

ratio

0.40

277

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.04

0.09

1.2

1.1

0.04

0.02

u/ml

—

(3013637) Mi-2 Ab [Presence] in Serum

204

1.08

0.08

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

204

1.08

0.08

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

204

1.08

0.08

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

204

1.08

0.08

1.2

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.03

0.08

1.3

1.4

—

(44806420) Estimation of glomerular filtration rate

683

0.97

0.08

2.8

2.5

—

(3005033) Fetal Nuchal fold Thickness US

368

0.95

0.07

1.5

1.4

1.23

1.26

0.13

253

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

439

0.96

0.07

1.5

1.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.08

0.07

1.6

2.6

1.13

0.54

u/field

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.05

0.07

1.4

1.1

—

(4133840) Spirometry

163

0.92

0.07

1.3

1.1

—

(3014891) Appearance of Pleural fluid

100

0.90

0.06

1.1

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

140

0.93

0.04

1.9

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

455

4521

1.01

0.04

1.4

1.3

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

349

1.03

0.03

9.1

5.7

41.00

208.34

u/ml

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

122

1.07

0.02

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

128

0.94

0.02

1.0

0.25

1.45

u/ml

—

(1617658) Protocol used for examination of sentinel lymph nodes

486

1.01

0.00

1.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

142

0.99

0.00

1.4

1.3

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.89

-0.00

6.0

6.6

8.00

7.79

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.91

-0.00

1.0

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.50

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.97

-0.00

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

31.67

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3034092) Cytoplasmic Ig cells/cells in Blood

0.93

-0.00

7.6

8.9

0.19

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.89

-0.00

3.0

3.3

24.40

46.48

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.89

-0.00

1.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.07

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

174.17

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

1.48

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_OTHINT and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_OTHINT	2.269 [2.0, 2.57]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.275

During the follow-up period (1.1.1998 — 31.12.2019), 2745 out of 8346 females with K11_OTHINT died.

Males

Parameter	HR [95% CI]	p-value
K11_OTHINT	2.521 [2.18, 2.92]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.008

During the follow-up period (1.1.1998 — 31.12.2019), 2777 out of 8156 males with K11_OTHINT died.

Mortality risk

Mortality risk for people of age

years, who have K11_OTHINT.

N-year risk	Females	Males
1	0.175%	0.453%
5	1.332%	2.727%
10	3.489%	6.975%
15	6.572%	13.4%
20	11.598%	22.801%

Relationships between endpoints

↥

Index endpoint: K11_OTHINT – Other diseases of intestine

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other diseases of intestine

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints